Publications

Publication

Publications – 2013 -2014

1. Jalan R, Yurdaydin C, Bajaj JS, Acharya SK, Arroyo V, Lin HC, Gines P, Kim WR, Kamath PS; World Gastroenterology Organization Working Party. Toward an improved definition of acute – on – chronic liver failure. Gastroenterology. 2014;147(1):4-10.

2. Tuteja A, Siddiqui AB, Madan K, Goyal R, Shalimar, Sreenivas V, Kaur N, Panda SK, Narayanasamy K, Subodh S, Acharya SK. Mutation profiling of the hepatitis B virus strains circulating in North Indian population. PLoS One. 2014;9(3):e91150.

3. Mutreja D, Kotru M, Sazawal S, Ranjan R, Sharma A, Acharya SK, Saxena R. Hereditary and Acquired Thrombophilia in Splanchnic Vein Thrombosis: A Single-Center Experience. Clin Appl Thromb Hemost. 2013. [Epub ahead of print]

4. Sengupta S, Panda SK, Acharya SK, Durgapal H. Role of hepatitis B virus genotype D & its mutants in occult hepatitis B infection. Indian J Med Res. 2013;138(3):329-39.

5. Acharya SK. This is hepatitis: know it, confront it. Indian J Med Res. 2013;138:8-10.

6. Shalimar, Acharya SK. Difficult to treat spontaneous bacterial peritonitis. Trop Gastroenterol. 2013;34(1):7-13.

7. Goyal R, Mallick SR, Mahanta M, Kedia S, Shalimar, Dhingra R, Sharma H, Das P, Datta Gupta S, Panda S, Acharya SK. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B. J Gastroenterol Hepatol. 2013;28(11):1738-45.

8. Pal S, Mangla V, Radhakrishna P, Sahni P, Pande GK, Acharya SK, Chattopadhyay TK, Nundy S. Surgery as primary prophylaxis from variceal bleeding in patients with extrahepatic portal venous obstruction. J Gastroenterol Hepatol. 2013;28(6):1010-4.

9. Kapil U, Pandey RM, Prakash S, Kabra M, Sareen N, Bhadoria AS. Assessment of iodine deficiency in school age children in Nainital District, Uttarakhand State. Asia Pac J Clin Nutr. 2014;23(2):278-81. doi: 10.6133/apjcn.2014.23.2.03. PubMed PMID: 24901098.

10. Sachdev HP, Kapil U. Authors' response. Indian J Med Res. 2014 Feb;139:324-5. PubMed PMID: 24843899; PubMed Central PMCID: PMC4001349.

11. Kapil U, Kabra M, Sareen N, Khenduja P, Pande S. Iodine nutrition status amongst neonates in Kangra district, Himachal Pradesh. J Trace Elem Med Biol. 2014 Jul;28(3):351-3. doi: 10.1016/j.jtemb.2014.03.009. Epub 2014 Apr 5. PubMed PMID: 24797042.

12. Kapil U, Jain V, Kabra M, Pandey RM, Sareen N, Khenduja P. Prevalence of neonatal hypothyroidism in Kangra Valley, Himachal Pradesh. Eur J Clin Nutr. 2014 Jun;68(6):748-9. doi: 10.1038/ejcn.2014.71. Epub 2014 Apr 23. PubMed PMID: 24755928.

13. Kapil U, Sareen N. Delivering Sprinkles Plus through the Integrated Child Development Services (ICDS) to Reduce Anemia in Pre-School Children in India: Correspondence. Indian J Pediatr. 2014 Mar 29. [Epub ahead of print] PubMed PMID: 24682810.

14. Kapil U, Prakash S, Sareen N, Bhadoria AS, Khenduja P, Nigam S, Vijay J. Status of iodine deficiency among pregnant mothers in Himachal Pradesh, India. Public Health Nutr. 2014 Mar 6:1-4. [Epub ahead of print] PubMed PMID: 24598389.

15. Kapil U, Kabra M, Prakash S, Sareen N, Khenduja P. Iodine Nutritional Status Among Neonates in the Solan District, Himachal Pradesh, India. J Community Health. 2014 Feb 22. [Epub ahead of print] PubMed PMID: 24563104.

16. Bhadoria AS, Kapil U, Sareen N, Singh P. Reproductive factors and breast cancer: A case-control study in tertiary care hospital of North India. Indian J Cancer. 2013 Oct-Dec;50(4):316-21. doi: 10.4103/0019-509X.123606. PubMed PMID: 24369207.

17. Sareen N, Bhadoria AS, Kapil U. Increase in hemoglobin among the mothers at different levels of hemoglobin. Indian J Community Med. 2013 Oct;38(4):249. doi: 10.4103/0970-0218.120164. PubMed PMID: 24302830; PubMed Central PMCID: PMC3831699.

18. Kapil U, Bhadoria AS, Sareen N, Kaur S. Association of body mass index and waist circumference with hypertension among school children in the age group of 5-16 years belonging to lower income group and middle income group in National Capital Territory of Delhi. Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S345-8. doi: 10.4103/2230-8210.119614. PubMed PMID: 24251210; PubMed Central PMCID: PMC3830356.

19. Kapil U, Sachdev HP. Massive dose vitamin A programme in India--need for a targeted approach. Indian J Med Res. 2013 Sep;138(3):411-7. PubMed PMID: 24135191; PubMed Central PMCID: PMC3818610.

20. Chander S, Kapil U, Jain V, Sareen N. Iodine deficiency disorders in school age children in Kullu District, Himachal Pradesh. Indian Pediatr. 2013 Sep;50(9):883-4. PubMed PMID: 24096846.

21. Kaur S, Sachdev H, Dwivedi SN, Lakshmi R, Kapil U, Sareen N. Association of obesity with hypertension amongst school-age children belonging to lower income group and middle income group in national capital territory of delhi. Indian J Community Med. 2013 Jul;38(3):175-9. doi: 10.4103/0970-0218.116355. PubMed PMID: 24019604; PubMed Central PMCID: PMC3760327.

22. Kapil U, Bhadoria AS, Sareen N. Correlates of zinc deficiency among children in age group of six to sixty months belonging to the low-income group. J Family Community Med. 2013 May;20(2):139-40. doi: 10.4103/2230-8229.114778. PubMed PMID:23983568; PubMed Central PMCID: PMC3748650.

23. Kapil U, Bhadoria AS. Assessment of energy expenditure among obese and non-obese children in national capital territory of Delhi. Indian J Public Health. 2013 Apr-Jun;57(2):119-21. doi: 10.4103/0019-557X.114985. PubMed PMID: 23873204.

24. Kapil U, Pandey RM, Jain V, Kabra M, Sareen N, Bhadoria AS, Vijay J, Nigam S, Khenduja P. Increase in iodine deficiency disorder due to inadequate sustainability of supply of iodized salt in District Solan, Himachal Pradesh. J Trop Pediatr. 2013 Dec;59(6):514-5. doi: 10.1093/tropej/fmt060. Epub 2013 Jul 18. PubMed PMID: 23868574.

25. Kapil U, Pandey RM, Kabra M, Jain V, Sareen N, Bhadoria AS, Vijay J, Nigam S, Khenduja P. Status of iodine deficiency in district Kangra, Himachal Pradesh after 60 years of salt iodization. Eur J Clin Nutr. 2013 Aug;67(8):827-8. doi:10.1038/ejcn.2013.119. Epub 2013 Jul 3. PubMed PMID: 23820337.

26. Garg P, Kaur S, Gupta D, Osmond C, Lakshmy R, Sinha S, Kapil U, Sachdev HP. Variability of thinness and its relation to cardio-metabolic risk factors using four body mass index references in school-children from Delhi, India. Indian Pediatr. 2013 Nov 8;50(11):1025-32. PubMed PMID: 23798637.

27. Kapil U, Sareen N. Prevalence of ferritin, folate and vitamin B" deficiencies amongst children in 5-18 years of age in Delhi. Indian J Pediatr. 2014 Mar;81(3):312. doi: 10.1007/s12098-013-1091-y. Epub 2013 Jun 20. PubMed PMID: 23783764.

28. Kapil U, Bhadoria AS, Sareen N. Serum concentration of selenium among normal healthy adult women in the National Capital Territory (NCT) of Delhi. Biol Trace Elem Res. 2013 Aug;154(2):167. doi: 10.1007/s12011-013-9726-4. Epub 2013 Jun 19. PubMed PMID: 23780469.

29. Kapil U, Dwivedi S, Sachdev HS, Dwivedi S, Pandey R, Hirdyani H, Upadhyay A. Resolution of Bitot's spots following mega-dose vitamin A supplementation in children between 1 and 5 years of age. Public Health Nutr. 2014 Jul;17(7):1614-9. doi: 10.1017/S1368980013001584. Epub 2013 Jun 17. PubMed PMID: 23768518.

30. Indian Academy of Pediatrics, Dalwai S, Choudhury P, Bavdekar SB, Dalal R, Kapil U, Dubey AP, Ugra D, Agnani M, Sachdev HP; Indian Academy of Pediatrics. Consensus Statement of the Indian Academy of Pediatrics on integrated management of severe acute malnutrition. Indian Pediatr. 2013 Apr;50(4):399-404. PubMed PMID: 23665599.

31. Bhatnagar M, Kapil U, Gujral H. Human milk banks and their relevance in India. Indian J Pediatr. 2014 Feb;81(2):220-1. doi: 10.1007/s12098-013-1061-4. Epub 2013 May 9. PubMed PMID: 23658064.

32. Kapil U, Sareen N, Bhadoria AS. Status of iodine deficiency among children in national capital territory Of Delhi--a cross-sectional study. J Trop Pediatr. 2013 Aug;59(4):331-2. doi: 10.1093/tropej/fmt025. Epub 2013 May 6. PubMed PMID: 23650151.

33. Kapil U, Bhadoria AS, Sareen N, Singh P, Dwivedi SN. Total cholesterol and triglyceride levels in patients with breast cancer. J Breast Cancer. 2013 Mar;16(1):129-30. doi: 10.4048/jbc.2013.16.1.129. Epub 2013 Mar 31. PubMed PMID: 23593095; PubMed Central PMCID: PMC3625762.

34. Kapil U, Sachdev HP, Dwivedi SN, Pandey RM, Upadhyay AD, Sareen N. Relative efficacy of weekly and two differing doses of daily iron-folate supplementation in improving hemoglobin in mild and moderately anemic children between 3 and 5 years of age: a cluster randomized trial. Eur J Clin Nutr. 2013 Apr;67(4):343-7. doi: 10.1038/ejcn.2013.13. Epub 2013 Feb 13. PubMed PMID: 23403883.

35. Garg PK, Mouli VP, Sreenivas V. Reply: To PMID 23063972. What is the role of noninvasive treatment for infected pancreatic necrosis: still an unanswered question. Gastroenterology. 2013;144:1575.

36. Bansal VK, Misra MC, Rajan K, Kilambi R, Kumar S, Krishna A, Kumar A, Pandav CS, Subramaniam R, Arora MK, Garg PK. Single-stage laparoscopic common bile duct exploration and holecystectomy versus two-stage endoscopic stone extraction followed by laparoscopic cholecystectomy for patients with concomitant gallbladder stones and common bile duct stones: a randomized controlled trial.Surg Endosc. 2014;28:875-85.

37. Jain K, Sreenivas V, Velpandian T, Kapil U, Garg PK. Risk factors for gallbladder cancer: A case-control study. Int J Cancer 2013;132:1660-6.

38. Jain K, Mohapatra T, Das P, Misra MC, Dutta Gupta S, Ghosh M, Kabra M, Bansal V, Kumar S, Sreenivas V, Garg PK . Sequential occurrence of pre-neoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer. Ann Surg 2014 Jan 22. [Epub ahead of print].

39. Singla V, Garg PK . Role of diagnostic and therapeutic endoscopic ultrasonography in benign pancreatic diseases. Endosc Ultrasound. 2013;2:134-41.

40. Kedia S, Dhingra R, Garg PK . Recurrent acute pancreatitis: an approach to diagnosis and management.Trop Gastroenterol. 2013;34:123-35.

41. Jacob TG, Raghav R, Kumar A, Garg PK, Roy TS. Duration of injury correlates with necrosis in caerulein-induced experimental acute pancreatitis: implications for pathophysiology. Int J Exp Pathol. 2014;95:199-208.

42. Madan K, Venuthurimilli A, Ahuja V, Hadda V, Mohan A, Guleria R. Tracheal Penetration and Tracheoesophageal Fistula Caused by an Esophageal Self-Expanding Metallic Stent. Case Rep Pulmonol. 2014;2014:567582.

43. Verma AK, Ahuja V, Paul J. The trend in distribution of Q223R mutation of leptin receptor gene in amoebic liver abscess patients from North India: a prospective study. Biomed Res Int. 2014;2014:847132.

44. Venigalla PM, Ahuja V. Colon rescue therapy in acute severe ulcerative colitis. Natl Med J India. 2013 May-Jun;26(3):159-61.

45. Sharma A, Aggarwal S, Ahuja V, Bal C. Evaluation of gastroesophageal reflux before and after sleeve gastrectomy using symptom scoring, scintigraphy, and endoscopy. Surg Obes Relat Dis. 2014 Jul-Aug;10(4):600-5.

46. Mouli VP, Gamnagatti S, Ahuja V. An unusual case of cyanosis in a young boy.Gastroenterology. 2013 Dec;145(6):e5-6.

47. Singla V, Pratap Mouli V, Garg SK, Rai T, Choudhury BN, Verma P, Deb R, Tiwari V, Rohatgi S, Dhingra R, Kedia S, Sharma PK, Makharia G, Ahuja V. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a

48. randomized, placebo-controlled, pilot study. J Crohns Colitis. 2014 Mar;8(3):208-14.

49. Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med. 2013 Aug 22;369(8):711-21.

50. Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J,Parikh A; GEMINI 1 Study Group. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013 Aug 22;369(8):699-710.

51. Kumari R, Ahuja V, Paul J. Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India. World J Gastroenterol. 2013 Jun 14;19(22):3404-14.

52. Verma N, Ahuja V, Paul J. Profiling of ABC transporters during active ulcerative colitis and in vitro effect of inflammatory modulators. Dig Dis Sci.2013 Aug;58(8):2282-92.

53. Meena NK, Verma R, Verma N, Ahuja V, Paul J. TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis. J Clin Gastroenterol. 2013 Oct;47(9):773-80.

54. Singh P, Wadhwa N, Chaturvedi MK, Bhatia V, Saini S, Tandon N, Makharia GK,Maki M, Not T, Phillips A, Bhatnagar S. Validation of point-of-care testing forcoeliac disease in children in a tertiary hospital in north India. Arch Dis Child.2014 Jun 18.pii: archdischild-2013-305567. doi:10.1136/archdischild-2013-305567. [Epub ahead of print]

55. Makharia GK. Intestinal permeabililty in portal hypertension: still a dilemma.Trop Gastroenterol. 2013 Jul-Sep;34 (3):119-22.

56. Makharia GK, Mulder CJ, Goh KL, Ahuja V, Bai JC, Catassi C, Green PH, GuptaSD, Lundin KE, Ramakrishna BS, Rawat R, Sharma H, Sood A, Watanabe C, Gibson PR; World Gastroenterology Organization-Asia Pacific Association of Gastroenterology Working Party on Celiac Disease. Issues associated with the emergence of coeliacdisease in the Asia–Pacific region: a working party report of the WorldGastroenterology Organization and the Asian Pacific Association of Gastroenterology.J GastroenterolHepatol. 2014 Apr;29 (4):666-77.

57. Singh P, Kurray L, Agnihotri A, Das P, Verma AK, Sreenivas V, Dattagupta S, Makharia GK. Titers of Anti-tissue Transglutaminase Antibody Correlate Well With Severity of Villous Abnormalities in Celiac Disease.J ClinGastroenterol.2014Feb 27. [Epub ahead of print]

58. Satyaraddi A, Velpandian T, Sharma SK, Vishnubhatla S, Sharma A, Sirohiwal A, Makharia GK, Sinha S, Biswas A, Singh S. Correlation of plasma anti-tuberculosis drug levels with subsequent development of hepatotoxicity. Int J Tuberc Lung Dis.2014 Feb;18(2):188-95,

59. Tak V, Mirdha BR, Yadav P, Vyas P, Makharia GK, Bhatnagar S. Molecular characterisation of Giardia intestinalis assemblages from human isolates at a tertiary care centre of India. Indian J Med Microbiol. 2014 Jan-Mar;32(1):19-25. doi: 10.4103/0255-0857.124290.

60. Rajpoot P, Makharia GK. Problems and challenges to adaptation of gluten free diet by Indian patients with celiac disease. Nutrients. 2013 Nov27;5(12):4869-79. doi: 10.3390/nu5124869.

61. Singh P, Arora S, Makharia GK. Presence of anemia in patients with celiac disease suggests more severe disease. Indian J Gastroenterol. 2014Mar;33(2):161-4.

62. Singh P, Shergill S, Makharia GK. Celiac disease in older adults. JGastrointestin Liver Dis. 2013 Sep;22(3):359-60.

63. Singla V, PratapMouli V, Garg SK, Rai T, Choudhury BN, Verma P, Deb R, Tiwari V, Rohatgi S, Dhingra R, Kedia S, Sharma PK, Makharia G, Ahuja V.Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study. J Crohns Colitis. 2014 Mar;8(3):208-14.

64. Ghoshal UC, Abraham P, Bhatia SJ, Misra SP, Choudhuri G, Biswas KD, Chakravartty K, Dadhich S, Goswami BD, Jayanthi V, Kumar S, Koshy A, Kumar KR,Makharia G, Nijhawan S, Pratap N, Ray G, Sachdeva S, Singh SP, Thomas V, UdawatH. Comparison of Manning, Rome I, II, and III, and Asian diagnostic criteria:report of the Multicentric Indian Irritable Bowel Syndrome (MIIBS) study. Indian J Gastroenterol. 2013 Nov;32(6):369-75.

65. Gupta R, Makharia G, Khadgawat R, Yadav RK. Evaluation of lactose and milk ntolerance, and bone mineral density in Indian patients with inflammatory bowel disease. Natl Med J India. 2012 Nov-Dec;25(6):327-31.

66. Kavimandan A, Sharma M, Verma AK, Das P, Mishra P, Sinha S, Mohan A, Sreenivas V, Datta Gupta S, Makharia GK. Prevalence of celiac disease in nutritional anemia at a tertiary care center. Indian J Gastroenterol. 2014 Mar;33(2):114-8.

67. Shalimar DM, Das P, Sreenivas V, Gupta SD, Panda SK, Makharia GK. Mechanismof villous atrophy in celiac disease: role of apoptosis and epithelial regeneration. Arch Pathol Lab Med. 2013 Sep;137(9):1262-9. doi: 10.5858/arpa.2012-0354-OA.

68. Singh P, Agnihotri A, Jindal G, Sharma PK, Sharma M, Das P, Gupta D, MakhariaGK. Celiac disease and chronic liver disease: is there a relationship? Indian JGastroenterol. 2013 Nov;32(6):404-8. doi: 10.1007/s12664-013-0352-z. Epub 2013Aug 7.

69. Sharma M, Singh P, Agnihotri A, Das P, Mishra A, Verma AK, Ahuja A, SreenivasV, Khadgawat R, Gupta SD, Makharia GK. Celiac disease: a disease with variedmanifestations in adults and adolescents. J Dig Dis. 2013 Oct;14(10):518-25. doi:10.1111/1751-2980.12078.

70. Morón B, Verma AK, Das P, Taavela J, Dafik L, Diraimondo TR, Albertelli MA,Kraemer T, Mäki M, Khosla C, Rogler G, Makharia GK. CYP3A4-catalyzed simvastatin metabolism as a non-invasive marker of small intestinal health in celiac disease.Am J Gastroenterol. 2013 Aug;108(8):1344-51.

71. Tuteja A, Siddiqui AB, Madan K, Goyal R, Shalimar, Sreenivas V, Kaur N, Panda SK, Narayanasamy K, Subodh S, Acharya SK. Mutation profiling of the hepatitis B virus strains circulating in North Indian population. PLoS One. 2014 Mar 17;9(3):e91150.

72. Goyal R, Mallick SR, Mahanta M, Kedia S, Shalimar, Dhingra R, Sharma H, Das P, Datta Gupta S, Panda S, Acharya SK. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B. J Gastroenterol Hepatol. 2013 Nov;28(11):1738-45.

73. Shalimar, Acharya SK. Difficult to treat spontaneous bacterial peritonitis. Trop Gastroenterol. 2013 Jan-Mar;34(1):7-13.

74. Madan K, Venkatnarayan K, Shalimar, Mohan A. Successful medical management of tuberculous broncho-oesophageal fistula. BMJ Case Rep. 2014 Mar 11;2014.

75. Shalimar, Das P, Sreenivas V, Gupta SD, Panda SK, Makharia GK. Mechanism of villous atrophy in celiac disease: role of apoptosis and epithelial regeneration. Arch Pathol Lab Med. 2013 Sep;137(9):1262-9.

76. Paldurai A, Kim SH, Nayak B, Xiao S, Shive H, Collins PL, Samal SK. (2014). Evaluation of the contributions of the individual viral genes to Newcastle disease virus virulence and pathogenesis. J Virol. 2014 May 21. pii: JVI.00666-14. [Epub ahead of print]

77. Khattar SK, Nayak B, Kim SH, Xiao S, Samal S, Paldurai A, Buchholz UJ, Collins PL, Samal SK.Evaluation of the replication, pathogenicity, and immunogenicity of avian paramyxovirus (APMV) serotypes 2, 3, 4, 5, 7, and 9 in rhesus macaques. PLoS One. 2013 Oct 10;8(10):e75456. doi: 10.1371/journal.pone.0075456.

78. Xiao S, Paldurai A, Nayak B, Mirande A, Collins PL, Samal SK. Complete genome sequence of a highly virulent newcastle disease virus currently circulating in Mexico. Genome Announc. 2013 Jan;1(1). doi:pii: e00177-12. 10.1128/genomeA.00177-12. Epub 2013 Feb 14. PubMed PMID: 23409252; PubMed Central PMCID: PMC3569268.

79. Parthiban M, Kaliyaperumal M, Xiao S, Nayak B, Paldurai A, Kim SH, Ladman BS, Preskenis LA, Gelb J Jr, Collins PL, Samal SK. Complete genome sequence of an avian paramyxovirus type 4 from north america reveals a shorter genome and new genotype. Genome Announc. 2013 Jan;1(1). doi:pii: e00075-12. 10.1128/genomeA.00075-12. Epub 2013 Jan 31. PubMedPMID: 23405329; PubMed Central PMCID: PMC3569320.

80. Samuel A, Nayak B, Paldurai A, Xiao S, Aplogan GL, Awoume KA, Webby RJ, Ducatez MF, Collins PL, Samal SK. Phylogenetic and pathotypic characterization of newcastle disease viruses circulating in west Africa and efficacy of a current vaccine. J Clin Microbiol. 2013 Mar;51(3):771-81. doi: 1128/JCM.02750-12. Epub 2012 Dec 19. PubMed PMID: 23254128; PubMed Central PMCID: PMC3592067.

81. Nayak B, Nayak S, Paldurai A, Kumar S, De Nardi R, Terregino C, Collins PL, Samal SK. Evaluation of the genetic diversity of avian paramyxovirus type 4.Virus Res. 2013 Jan;171(1):103-10. doi:10.1016/j.virusres.2012.10.031. Epub 2012Nov 21. PubMed PMID: 23178589; PubMed Central PMCID: PMC3557600

2015-16

1. Shalimar, Kumar A, Kedia S, Sharma H, Gamanagatti SR, Gulati GS, Nayak B, Thakur B, Acharya SK. Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score. Aliment PharmacolTher. 2016 Apr 7.doi: 10.1111/apt.13604.
2. Shalimar, Saraswat V, Singh S, Duseja A, Shukla A, Eapen CE, Kumar D, Pandey G, Venkataraman J, Narayanswami K, Puri P, Dhiman RK, Thareja S, Nijhawan S, Bhatia S, Zachariah U, Sonika U, Thomas V, Acharya SK. Acute on chronic liver failure in India: the INASL Consortium experience. J GastroenterolHepatol. 2016 Mar 16. doi: 10.1111/jgh.13340.
3. Sankhyan A, Sharma C, Dutta D, Sharma T, Chosdol K, Wakita T, Watashi K, Awasthi A, Acharya SK, Khanna N, Tiwari A, Sinha S. Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals.Sci Rep. 2016;6:21240.
4. Srivastava S, Shalimar, Vishnubhatla S, Prakash S, Sharma H, Thakur B, Acharya SK. Randomized controlled trial comparing the efficacy of terlipressin and albumin with a combination of concurrent dopamine, furosemide, and albumin in hepatorenal syndrome. J ClinExpHepatol. 2015;5:276-85.
5. Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Sarin SK, Singh SP, Chawla YK, Aggarwal R, Amarapurkar D, Arora A, Dixit VK, Sood A, Shah S, Duseja A, Kapoor D, Shalimar, Madan K, Pande G, Nagral A, Kar P, Koshy A, Puri AS, Eapen CE, Thareja S. Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015. J ClinExpHepatol. 2015;5:221-38.
6. Shalimar, Kumar D, Vadiraj PK, Nayak B, Thakur B, Das P, Datta Gupta S, Panda SK, Acharya SK. Acute on chronic liver failure due to acute hepatic insults: Etiologies, course, extrahepatic organ failure and predictors of mortality.   J GastroenterolHepatol. 2016;31:856 -64.
7. Dhamija E, Paul SB, Gamanagatti SR, Acharya SK.  Biliary complications of arterial chemoembolization of hepatocellular carcinoma.  DiagnInterv Imaging. 2015;96:1169-75.
8. Shalimar, Acharya SK.  Management of acute liver failure.  J ClinExpHepatol. 2015;5(Suppl 1):S104-15.
9. Acharya SK, Paul SB. Editorial: hepatocellular carcinoma – a rare complication of hepatic venous outflow tract obstruction author’s reply. Aliment PharmacolTher. 2015;41:1213-4.
10. Singh S, Saraya A, Sharma R. Increased levels of sperm protein 17 mRNA and circulating antibodies in periampullary carcinoma patients. Int J ClinOncol. 2015 20:736-44.
11. Pratap Mouli V, Benjamin J, Bhushan Singh M, Mani K, Garg SK, Saraya A, Joshi YK. Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial. Hepatol Res. 2015;45:880-9.
12. Singh N, Gupta S, Pandey RM, Chauhan SS, Saraya A. High levels of cell-free circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis and poor survival. Cancer Invest. 2015;33:78-85.
13. Balakrishna P, Parshad R, Rohila J, Saraya A, Makharia G, Sharma R. Symptomatic outcome following laparoscopic Heller's cardiomyotomy with Dor fundoplication versus laparoscopic Heller's cardiomyotomy with angle of His accentuation: results of a randomized controlled trial. SurgEndosc. 2015;29:2344-51.
14. SareenN, Kapil U. Controversies Continue: Universal Supplementation of Megadose of Vitamin A to Young Children in India. Indian J Community Med. 2016;41:89-92.
15. Sareen N, Kapil U, Nambiar V, Pandey RM, Khenduja P. Iodine nutritional status in Uttarakhand State, India. Indian J EndocrinolMetab. 2016;20:171-6.
16. Sachdev HP, Kapil U. Neonatal Vitamin A supplementation for improving infant survival: Hope or hype? Natl Med J India. 2015;28:64-5.
17. Kapil U, Sareen N, Nambiar VS, Khenduja P, Sofi NY. Iodine nutritional status among adolescent girls in Uttarakhand, India. J Trop Pediatr. 2016 Feb;62(1):81-2.
18. Bhadoria AS, Kapil U, Kaur S. Association of Duration of Time Spent on Television, Computer and Video Games with Obesity amongst Children in National Capital Territory of Delhi. Int J Prev Med. 2015;6:80.
19. Kapil U, Pandey RM, Sareen N, Khenduja P, Bhadoria AS. Iodine nutritional status in Himachal Pradesh state, India. Indian J EndocrinolMetab. 2015;19:602-7.
20. Bhadoria AS, Kapil U. Overweight and obesity amongst children. Natl Med J India. 2015 Feb;28:48.
21. Bhadoria AS, Kapil U. Television viewing and overweight and obesity amongst children. Biomed J. 2015;38:96.
22. Whitcomb DC, Frulloni L, Garg P, Greer JB, Schneider A, Yadav D, Shimosegawa T.  Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016;16:218-24. 
23. Agarwal S, George J, Padhan RK, Vadiraja PK, Behera S, Hasan A, Dhingra R, Shalimar, Garg PK. Reduction in mortality in severe acute pancreatitis: A time trend analysis over 16 years.Pancreatology. 2016;16:194-9.
24. Giri AK, Midha S, Banerjee P, Agrawal A, Mehdi SJ, Dhingra R, Kaur I, G RK, Lakhotia R, Ghosh S, Das K, Mohindra S, Rana S, Bhasin DK, Garg PK, Bharadwaj D; INDIPAN and INDICO Consortium. Common Variants in CLDN2 and MORC4 Genes Confer Disease Susceptibility in Patients with Chronic Pancreatitis. PLoS One. 2016;11:e0147345.
25. Gamanagatti S, Thingujam U, Garg P, Nongthombam S, Dash NR. Endoscopic ultrasound guided thrombin injection of angiographically occult pancreatitis associated visceral artery pseudoaneurysms: Case series. World J GastrointestEndosc. 2015;7:1107-13.
26. Garg PK, Imrie CW. Severity classification of acute pancreatitis: The continuing search for a better system. Pancreatology 2015;15:99-100.
27. Tang SJ, Vilmann AS, Saftoiu A, et al. EUS Needle Identification Comparison and Evaluation study (with videos). GastrointestEndosc. 2016 Feb 10.pii: S0016-5107.
28. Gamanagatti S, Singh T, Sharma R, Srivastava DN, Dash NR, Garg PK. Unilobar versus bilobar biliary drainage: Effect on quality of life and bilirubin level reduction. Indian J Palliat Care. 2016;22:50-62.
29. Khan IA, Pilli S, A S, Rampal R, Chauhan SK, Tiwari V, Mouli VP, et al. Prevalence and Association of Mycobacterium avium subspecies paratuberculosis with Disease Course in Patients with Ulcero-Constrictive Ileocolonic Disease.PLoS One. 2016 28;11:e0152063.
30. Kedia S, Rampal R, Paul J, Ahuja V. Gut microbiome diversity in acuteinfective and chronic inflammatory gastrointestinal diseases in North India. JGastroenterol. 2016 Mar 19. [Epub ahead of print]
31. Rampal R, Awasthi A, Ahuja V. Retinoic acid-primed human dendritic cellsinhibit Th9 cells and induce Th1/Th17 cell differentiation. J Leukoc Biol. 2016 Mar 15. pii: jlb.3VMA1015-476R. [Epub ahead of print] PubMed PMID: 26980802.
32. Singh UB, Pandey P, Mehta G, Bhatnagar AK, Mohan A, GoyalV,et al. Genotypic, phenotypic and clinicalvalidation of GeneXpert in extra-Pulmonary and pulmonary tuberculosis in India.PLoS One. 2016 Feb 19;11(2):e0149258.
33. Kedia S, Kurrey L, PratapMouli V, Dhingra R, Srivastava S, Pradhan R, et al.Frequency, natural course and clinicalsignificance of symptomatic terminal ileitis. J Dig Dis. 2016 ;17:36-43.
34. Ranjha R, Aggarwal S, Bopanna S, Ahuja V, Paul J. Site-Specific MicroRNAExpression May Lead to Different Subtypes in Ulcerative Colitis. PLoS One. 2015;10(11):e0142869.
35. Ahuja V. Inventory of a reservoir: friends & foes. Indian J Med Res. 2015Jul;142(1):4-6. doi: 10.4103/0971-5916.162085.
36. Ahuja V, Subodh S, Tuteja A, Mishra V, Garg SK, Gupta N, MakhariaG,etal.Genome-wide gene expression analysis for target genes to differentiatepatients with intestinal tuberculosis and Crohn's disease and discriminativevalue of FOXP3 mRNA expression. Gastroenterol Rep (Oxf). 2016;4:59-67.
37. Srivastava S, Kedia S, Kumar S, PratapMouli V, Dhingra R, Sachdev V, et al. Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity. JCrohns Colitis. 2015;9:575-9.
38. Ooi CJ, Makharia GK, Hilmi I, Gibson PR, Fock KM, Ahuja V,etal.; Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease. Asia-Pacific consensusstatements on Crohn's disease. Part 2: Management. J GastroenterolHepatol. 2016 Jan;31(1):56-68.
39. Ooi CJ, Makharia GK, Hilmi I, Gibson PR, Fock KM, Ahuja V, et al.Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease. Asia Pacific ConsensusStatements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology:(Asia Pacific Crohn's Disease Consensus-Part 1). J GastroenterolHepatol. 2016;31:45-55.
40. Rukmangadachar LA, Makharia GK, Mishra A, Das P, Hariprasad G, Srinivasan A, Gupta SD, Ahuja V, Acharya SK. Proteome analysis of the macroscopically affected colonic mucosa of Crohn's disease and intestinal tuberculosis. Sci Rep. 2016;6:23162.
41. Singh I, Agnihotri A, Sharma A, Verma AK, Das P, Thakur B, Sreenivas V, Gupta SD, Ahuja V, Makharia GK. Patients with celiac disease may have normal weight or may even be overweight. Indian J Gastroenterol. 2016 Feb 18. [Epub ahead of print] PubMed PMID: 26892766.
42. Das R, Khalil S, Mirdha BR, Makharia GK, Dattagupta S, Chaudhry R. Molecular Characterization and Subtyping of Blastocystis Species in Irritable Bowel Syndrome Patients from North India. PLoS One. 2016 Jan 19;11(1):e0147055.
43. Ramakrishna BS, Makharia GK, Chetri K, Dutta S, Mathur P, Ahuja V, Amarchand R, Balamurugan R, Chowdhury SD, Daniel D, Das A, George G, Gupta SD, Krishnan A, Prasad JH, Kaur G, Pugazhendhi S, Pulimood A, Ramakrishna K, Verma AK. Prevalence of Adult Celiac Disease in India: Regional Variations and Associations. Am J Gastroenterol. 2016 Jan;111(1):115-23.
44. Mishra A, Prakash S, Kaur G, Sreenivas V, Ahuja V, Gupta SD, Makharia GK. Prevalence of celiac disease among first-degree relatives of Indian celiac disease patients. Dig Liver Dis. 2016 ;48):255-9.
45. Makharia A, Catassi C, Makharia GK. The Overlap between Irritable Bowel Syndrome and Non-Celiac Gluten Sensitivity: A Clinical Dilemma. Nutrients. 2015;7:10417-26.
46. Singh P, Arora S, Singh A, Strand TA, Makharia GK. Prevalence of Celiac disease in Asia: A systematic review and meta-analysis. J GastroenterolHepatol. 2015 Dec 18. doi: 10.1111/jgh.13270. [Epub ahead of print] PubMed PMID: 26678020.
47. Rajpoot P, Sharma A, Harikrishnan S, Baruah BJ, Ahuja V, Makharia GK. Adherence to gluten-free diet and barriers to adherence in patients with celiac disease. Indian J Gastroenterol. 2015 ;34:380-6.
48. Mishra A, Prakash S, Sreenivas V, Das TK, Ahuja V, Gupta SD, Makharia GK. Structural and functional changes in the tight junctions of asymptomatic and serology-negative first-degree relatives of patients withceliac disease. J ClinGastroenterol. 2015 Oct 31. [Epub ahead of print] PubMed PMID: 26535478.
49. Sharma P, Makharia G, Yadav R, Dwivedi SN, Deepak KK. Gastric myoelectrical activity in patients with inflammatory bowel disease. J Smooth Muscle Res. 2015;51:50-7.
50. Singh P, Arora S, Lal S, Strand TA, Makharia GK. Risk of Celiac Disease in the First- and Second-Degree Relatives of Patients With Celiac Disease: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2015;110:1539-48.
51. See JA, Kaukinen K, Makharia GK, Gibson PR, Murray JA. Practical insights into gluten-free diets. Nat Rev GastroenterolHepatol. 2015;12:580-91.
52. Saha S, Saini S, Makharia GK, Datta Gupta S, Goswami R. Prevalence of coeliac disease in idiopathic hypoparathyroidism and effect of gluten-free diet on calcaemic control. ClinEndocrinol (Oxf). 2016;84:578-86.
53. Yadav P, Khalil S, Mirdha BR, Makharia GK, Bhatnagar S. Molecular characterization of clinical isolates of Cyclosporacayetanensis from patients with diarrhea in India. Indian J Med Microbiol. 2015 Jul-Sep;33(3):351-6.
54. Makharia GK, Ghoshal UC, Ramakrishna BS, Agnihotri A, Ahuja V, Chowdhury SD,Gupta SD, Mechenro J, Mishra A, Mishra A, Pathak MK, Pandey RM, Sharma R, Sharma SK. Intermittent Directly Observed Therapy for Abdominal Tuberculosis: A Multicenter Randomized Controlled Trial Comparing 6 Months Versus 9 Months of Therapy. Clin Infect Dis. 2015 ;61:750-7
55. Sharma H, Verma AK, Das P, Dattagupta S, Ahuja V, Makharia GK. Prevalence of celiac disease in Indian patients with irritable bowel syndrome and uninvestigated dyspepsia. J Dig Dis. 2015;16:443-8.
56. Makharia GK. Celiac disease screening in southern and East Asia. Dig Dis. 2015;33:167-74.
57. Sharma U, Upadhyay D, Mewar S, Mishra A, Das P, Gupta SD, Dwivedi SN, Makharia GK, Jagannathan NR. Metabolic abnormalities of gastrointestinal mucosa in celiac disease: An in vitro proton nuclear magnetic resonance spectroscopy study. J GastroenterolHepatol. 2015 ;30:1492-8.
58. Singh P, Arora S, Lal S, Strand TA, Makharia GK. Celiac Disease in Women With Infertility: A Meta-Analysis. J ClinGastroenterol. 2016;50:33-9.
59. Goyal A, Madhusudhan KS, Gamanagatti S, Baruah B, Shalimar, Sharma R.Radiological management of multiple hepatic artery pseudoaneurysms associated with cholangitic abscesses. Indian J Radiol Imaging. 2016;26:99-102.
60. Nair VP, Anang S, Subramani C, Madhvi A, Bakshi K, Srivastava A, Shalimar, Nayak B, CT RK, Surjit M. Endoplasmic Reticulum Stress Induced Synthesis of a Novel Viral Factor Mediates Efficient Replication of Genotype-1 Hepatitis E Virus. PLoSPathog. 2016;12:e1005521.
61. Agarwal S, George J, Padhan RK, Vadiraja PK, Behera S, Hasan A, Dhingra R, Shalimar, Garg PK. Reduction in mortality in severe acute pancreatitis: A time trend analysis over 16 years. Pancreatology. 2016 Mar-Apr;16(2):194-9. doi:10.1016/j.pan.2016.01.012. Epub 2016 Feb 10. PubMed PMID: 26915280.
62. Shalimar. Use of non-selective beta-blockers in decompensated cirrhosis:Controversy continues. J ClinExpHepatol. 2015;5:352-4.
63. Bopanna S, Shalimar. Intestinal FXR: A New Therapeutic target for nonalcoholicfatty liver disease. J ClinExpHepatol. 2015;5:264-6.
64. Madhusudhan KS, Gamanagatti S, Garg P, Shalimar, Dash NR, Pal S, Peush S, Gupta AK. Endovascular embolization of visceral artery pseudoaneurysms using modified Injection Technique with N-Butyl Cyanoacrylate Glue. J VascIntervRadiol. 2015;26:1718-25.
65. Shalimar. Role of pentoxifylline and steroids for alcoholic hepatitis – Has the last word been said? J ClinExpHepatol. 2015;5(2):170-2.
66. Shalimar, Acharya SK. Management in acute liver failure. J ClinExpHepatol. 2015;5(Suppl 1):S104-15.
67. Shalimar. Antibiotics in acute liver failure (ALF). J ClinExpHepatol. 2015;5(1):95-7
68. Paul SB, Shalimar, Sreenivas V, Gamanagatti SR, Sharma H, Dhamija E, Acharya SK. Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction. Aliment PharmacolTher. 2015;41:961-71.
69. Dhamija E, Madhusudhan KS, Shalimar, Das P, Srivastava DN, Gupta AK. Primary hepatic diffuse large B-cell lymphoma: unusual presentation and imaging features.CurrProblDiagnRadiol. 2015;44:290-3.
70. Mondal K, Chakravarti S, Ghosh AK, Kumar S, Nayak B, Nandi S, Sarkar U, Deb R, De A, Biswas J. Novel identification of Factor XI deficiency in Indian Sahiwal (Bos indicus) cattle. MolBiol Rep. 2016;43:213-9.
71. N Singh, A Saraya. Circulating nucleic acids: An Overview. Chemotherapy: Open Access 2015; 4:172.
72. Singh N, Gupta S, Pandey RM, Sahni P, Chauhan SS,  Saraya A.  Study on prognostic significance of plasma Matrix Metalloprotease-2 (MMP-2) in pancreatic cancer patients. Indian Journal of Medical Research (accepted).
73. Singh N, Saraya S. Role of Cathepsins in pancreatic cancer. Tropical Gastroenterology 2016;37:77-85.

2017-18

1. Kedia S, Sharma R, Makharia GK, Ahuja V, Desai D, Kandasamy D, Eapen A, Ganesan K, Ghoshal UC, Kalra N, Karthikeyan D, Madhusudhan KS, Philip M, Puri AS, Puri S, Sinha SK, Banerjee R, Bhatia S, Bhat N, Dadhich S, Dhali GK, Goswami BD,  Issar SK, Jayanthi V, Misra SP, Nijhawan S, Puri P, Sarkar A, Singh SP, Srivastava A, Abraham P, Ramakrishna BS; for Indian Society of Gastroenterology Task Force on Inflammatory Bowel Disease. Imaging of the small intestine in Crohn's disease: Joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association. Indian J Gastroenterol. 2017;36:487-508.
2. Venugopal G, Mechenro J, Makharia G, Singh A, Pugazhendhi S, Balamurugan R, Ramakrishna BS. Sequential testing with different tissue transglutaminase antibodies, a new approach for diagnosis of celiac disease. Indian J Gastroenterol. 2017;36:481-486.
3. Singh P, Makharia GK. Avoiding biopsy for initial diagnosis for celiac disease: are we there yet? Eur J Gastroenterol Hepatol. 2017;29:1189.
4. Khalil S, Mirdha BR, Panda A, Singh Y, Makharia G, Paul J. Cryptosporidium species subtypes and associated clinical manifestations in Indian patients. Gastroenterol Hepatol. 2017;10:311-318.
5. Gupta V, Makharia G. VonMeyenburg complexes in a patient with obstructive jaundice. Med J Aust. 2017;207:239.
6. Baruah B, Kumar T, Das P, Thakur B, Sreenivas V, Ahuja V, Gupta SD, Makharia GK. Prevalence of eosinophilic esophagitis in patients with gastroesophageal reflux symptoms: A cross-sectional study from a tertiary care hospital in North India. Indian J Gastroenterol. 2017;36:353-360.
7. Shergill S, Makharia GK. Awareness about celiac disease amongst physicians. Indian J Gastroenterol. 2017;36:327-329.
8. Dhawan B, Makharia GK, Juyal D, Sebastian S, Bhatia R, Khanna N. Chlamydia trachomatis proctitis masquerading as carcinoma rectum: First case report from India. Indian J PatholMicrobiol. 2017;60:259-261.
9. Paul SB, Das P, Mahanta M, Sreenivas V, Kedia S, Kalra N, Kaur H, Vijayvargiya M, Ghosh S, Gamanagatti SR, Shalimar, Gupta SD, Acharya SK. Assessment of liver fibrosis in chronic hepatitis: comparison of shear wave elastography and transient elastography. AbdomRadiol (NY). 2017 Dec;42(12):2864-2873.
10. Shalimar, Kedia S, Sharma H, Vasudevan S, Sonika U, Upadhyaya AD, Acharya SK. Predictors of infection in viral-hepatitis related acute liver failure. Scand J Gastroenterol. 2017 Dec;52(12):1413-1419. doi: 10.1080/00365521.2017.1374449. Epub 2017 Sep 6. PubMed PMID: 28875762.
11. Kaushik N, Subramani C, Anang S, Muthumohan R, Shalimar, Nayak B, Ranjith-Kumar CT, Surjit M. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase. J Virol. 2017 Oct 13;91(21).
12. Shalimar, Gamanagatti SR, Patel AH, Kedia S, Nayak B, Gunjan D, Ranjan G, Paul SB, Acharya SK. Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome. Eur J Gastroenterol Hepatol.2017 ;29:1174-1182.
13. Shalimar, Kedia S, Mahapatra SJ, Nayak B, Gunjan D, Thakur B, Acharya SK. Severity and outcome of acute-on-chronic liver failure is dependent on the etiology of acute hepatic insults: Analysis of 368 patients. J Clin Gastroenterol. 2017;51:734-741.
14. Gunjan D, Shalimar, Nadda N, Kedia S, Nayak B, Paul SB, Gamanagatti SR, Acharya SK. Hepatocellular Carcinoma: An unusual complication of longstanding Wilson disease. J ClinExpHepatol. 2017;7:152-154.
15. Shalimar, Kedia S, Gunjan D, Sonika U, Mahapatra SJ, Nayak B, Kaur H, Acharya SK. Acute liver failure due to Hepatitis E Virus infection is associated with better survival than other etiologies in Indian patients. Dig Dis Sci. 2017;62:1058-1066.
16. Taneja N, Khadgawat R, Nayak B, Mani S. Study of mitochondrial DNA copy number variation in peripheral blood of type 2 diabetes patients: A pilot study. Int. J. Pharm. Sci. Rev. Res., 44(2), May - June 2017; Article No. 42, Pages: 210-214
17. Shalimar, Jain S, Gamanagatti SR, Kedia S, Thakur B, Nayak B, Kaur H, Gunjan D,Paul SB, Acharya SK. Role of Indocyanine Green in Predicting Post-Transarterial Chemoembolization Liver Failure in Hepatocellular Carcinoma. J ClinExpHepatol. 2017 https://doi.org/10.1016/j.jceh.2017.05.012.
18. Shalimar, Gamanagatti SR, Patel AH, Kedia S, Nayak B, Gunjan D, et al. Long-term outcomes of transjugular intrahepatic Portosystemic shunt in Indian patients with Budd-Chiari syndrome. Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1174-1182.
19. Shalimar, Sushil Jain, Shivanand R. Gamanagatti, Saurabh Kedia, Bhaskar Thakur, Deepak Gunjan, et al. Role of Indocyanine Green in Predicting Post-Transarterial Chemoembolization Liver Failure in Hepatocellular Carcinoma. J ClinExpHepatol 2017 (in press) https://doi.org/10.1016/j.jceh.2017.05.012.
20. Gunjan Deepak, Gill Kamaldeep , Rai Nitish , Soneja Manish , Bhalla Ashu S , Kumar Uma, et al. Surface Plasmon Resonance Mediated Evaluation of Cartilage Oligomeric Matrix Protein in serum of Elderly Patients with Knee Osteoarthritis: An Indian Perspective. JPBB Jan-June 2017;2:23-29.
21. Manchanda M, Das P, Gahlot GPS, Singh R, Roeb E, Roderfeld M, Datta Gupta S, Saraya A, Pandey RM, Chauhan SS. Cathepsin L and B as Potential Markers for Liver Fibrosis: Insights From Patients and Experimental Models.ClinTransl Gastroenterol. 2017;8:e99.
22. Bajpai V, Singh N, Sardana H, Khanna S, Vettiyil B, Saraya A.  Economic and social impact of out of pocket expenditure on households of patients attending public hospitals. Natl Med J India. 2017;30:15-20.
23. Singh N, Saraya A. The importance of nutrition as an integral part of disease management. Indian J Med Res 2017;144:949-50.
24. Singh N, Gupta S, Pandey RM, Sahni P, Chauhan SS, Saraya A. Study on prognostic significance of plasma Matrix Metalloprotease-2 (MMP-2) in pancreatic cancer patients. Indian Journal of Medical Research. Indian J Med Res. 2017;146:334-340.
25.  Pant K, Yadav AK, Gupta P, Islam R, Saraya A, Venugopal SK. Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells. Redox Biol. 2017 Mar 7;12:340-349. doi: 10.1016/j.redox.2017.03.006.
26. Goswami P, Sonika U, Moka P, Sreenivas V, Saraya P. Intestinal fatty acid binding protein (iFABP) and citrulline as markers of gut injury and prognosis in patients with acute pancreatitis. Pancreas. 2017;46:1275-1280.
27. Kishor Panta, Anoop Saraya, Senthil K, Venugopala. Oxidative stress plays a key role in butyrate-mediated autophagy via Akt/mTOR pathway in hepatoma cells. Chemico-Biological Interactions. Chemico-Biological Interactions 2017; 273:99e106.
28. Singh N, Gupta S, Pandey RM, Sahni P, Chauhan SS,  Saraya A. Prognostic significance of plasma matrix metalloprotease-2 in pancreatic cancer patients. Indian J Med Res. 2017;146:334-340.
29. Singh S, Saraya A, Das P, Sharma R. Increased expression of MARCH8, an E3 ubiquitin ligase, is associated with growth of esophageal tumor. Cancer Cell Int. 2017 Dec 4;17:116.
30. Drewes AM, Bouwense SAW, Campbell CM, et al. Working group for the International (IAP – APA – JPS – EPC) Consensus guidelines for chronic pancreatitis. Guidelines for the understanding and management of pain in chronic pancreatitis. Pancreatology. 2017;17:720-731.
31. Jagannath S, Garg PK. Novel and experimental therapies in chronic pancreatitis. Dig Dis Sci. 2017;62:1751-1761.
32. Bopanna S, Nayak B, Prakash S, Shalimar, Mahapatra SJ, Garg PK. Increased oxidative stress and deficient antioxidant levels may be involved in the pathogenesis of idiopathic recurrent acute pancreatitis. Pancreatology2017;17:529-533. 
33. Wyse JM, Battat R, Sun S, et al. Practice guidelines for endoscopic ultrasound-guided celiac plexus neurolysis. Endosc Ultrasound. 2017;6:369-375.
34. Guo J, Saftoiu A, Vilmann P, et al. A multi-institutional consensus on how to perform endoscopic ultrasound-guided peri-pancreatic fluid collection drainage and endoscopic necrosectomy. Endosc Ultrasound 2017;6:285-291. 
35. Goyal S, Rampal R, Kedia S, Mahajan S, Bopanna S, Yadav DP, … Ahuja V. Urinary potassium is a potential biomarker of disease activity in ulcerative colitis and displays in vitro immunotolerant role. Sci Rep. 2017;7:18068.
36. Yadav DP, Kedia S, Madhusudhan KS, Bopanna S, Goyal S, Jain S, …. Ahuja V. Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration. Can J Gastroenterol Hepatol. 2017; 2017:1215035.
37. Kedia S, Madhusudhan KS, Sharma R, Bopanna S, Yadav DP, Goyal S, … Ahuja V. Combination of increased visceral fat and long segment involvement: Development and validation of an updated imaging marker for differentiating Crohn's disease from intestinal tuberculosis. J Gastroenterol Hepatol. 2017 Dec 4. doi: 10.1111/jgh.14065. [Epub ahead of print]
38. Sonika U, Saha S, Kedia S, Dash NR, Pal S, Das P, Ahuja V. Predictive factors for malignancy in undiagnosed isolated small bowel strictures. Intest Res. 2017;15:518-523.
39. Jain S, Kedia S, Bopanna S, Sachdev V, Sahni P, Dash NR, ….Ahuja V. Faecal calprotectin and UCEIS predict short-term outcomes in acute severe colitis: Prospective cohort study. J Crohns Colitis. 2017;11:1309-1316.
40. Malik S, Sadhu S, Elesela S, Pandey RP, Chawla AS, Sharma D, ….Ahuja V. Transcription factor Foxo1 is essential for IL-9 induction in T helper cells. Nat Commun. 2017 ;8:815.
41. Aggarwal P, Kedia S, Sharma R, Bopanna S, Madhusudhan KS, Yadav DP, …Ahuja V. Tubercular Intestinal Strictures Show a Poor Response to Anti-Tuberculous Therapy. Dig Dis Sci. 2017;62:2847-2856.
42. Majumdar I, Ahuja V, Paul J. Altered expression of tumor necrosis factor alpha -induced protein 3 correlates with disease severity in ulcerative colitis. Sci Rep. 2017;7:9420.
43. Valmiki S, Ahuja V, Paul J. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients. World J Gastroenterol. 2017;23:5324-5332.
44. Bopanna S, Kedia S, Das P, Dattagupta S, Sreenivas V, Mouli VP, … Ahuja V. Long-term follow-up reveals high incidence of colorectal cancer in Indian patients with inflammatory bowel disease. United European Gastroenterol J. 2017;5:708-714.
45. Gupta A, Bopanna S, Kedia S, Yadav DP, Goyal S, Jain S, .. Ahuja V. Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis. Intest Res. 2017;15:388-394.
46. Aggarwal S, Ahuja V, Paul J. Attenuated GABAergic Signaling in intestinal epithelium contributes to pathogenesis of ulcerative colitis. Dig Dis Sci. 2017;62:2768-2779.
47. Mustfa SA, Singh M, Suhail A, Mohapatra G, Verma S, Chakravorty D, …Ahuja V. SUMOylation pathway alteration coupled with downregulation of SUMO E2 enzyme at mucosal epithelium modulates inflammation in inflammatory bowel disease. Open Biol. 2017;7. pii: 170024.
48. Kedia S, Bhatia V, Thareja S, Garg S, Mouli VP, Bopanna S, …. Ahuja V. Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial. World J GastrointestPharmacolTher. 2017;8:147-154.  
49. Kumar S, Bopanna S, Kedia S, Mouli P, Dhingra R, PadhanR, .. Ahuja V. Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis. Intest Res. 2017;15:187-194.
50. Kedia S, Sharma R, Sreenivas V, Madhusudhan KS, Sharma V, BopannaS, ..Ahuja V. Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysis. Intest Res. 2017;15:149-159.
51.  Bopanna S, Ananthakrishnan AN, Kedia S, Yajnik V, Ahuja V. Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2:269-276.
52.  Garg H, Vigneshwaran B, Aggarwal S, Ahuja V. Impact of concomitant laparoscopic sleeve gastrectomy and hiatal hernia repair on gastro-oesophageal reflux disease in morbidly obese patients. J Minim Access Surg. 2017;13:103-108.
53.  Sharma P, Saraya A, Sharma R. Serum based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets. Asia Pac J Clin Oncol. 2018 Jan 30.
54. Rashid S, Singh N, Gupta S, Rashid S, Nalika N, Sachdev V, Bal CS, Datta Gupta S, Chauhan SS, Saraya A. Progression of Chronic Pancreatitis to Pancreatic Cancer: Is There a Role of Gene Mutations as a Screening Tool? Pancreas. 2018 Feb;47(2):227-232.
55. Padhan RK, Jain S, Agarwal S, Harikrishnan S, Vadiraja P, Behera S, Jain SK, Dhingra R, Dash NR, Sahni P, Garg PK. Primary and secondary organ failures cause mortality differentially in acute pancreatitis and should be distinguished. Pancreas. 2018;47:302-307.
56. Vasudevan V, Goswami P, Sonika U, Thakur B, Sreenivas V, Saraya A. Comparison of various scoring systems and biochemical markers in predicting the outcome in acute pancreatitis.  Pancreas. 2018 Jan;47(1):65-71.
57. Saha SK, Panwar R, Kumar A, Pal S, Ahuja V, Dash NR, et al. Early colectomy in steroid-refractory acute severe ulcerative colitis improves operative outcome. Int J Colorectal Dis. 2018;33:79-82.
58. Jain S, Kedia S, Sethi T, Bopanna S, Yadav DP, Goyal S, …Ahuja V. Predictors of long-term outcomes in patients with acute severe colitis: A northern Indian cohort study. J Gastroenterol Hepatol. 2018;33:615-622.
59. Arora U, Ananthakrishnan AN, Kedia S, Bopanna S, Mouli PV, Yadav DP, …Ahuja V. Effect of oral tobacco use and smoking on outcomes of Crohn's disease in India. J Gastroenterol Hepatol. 2018;33:134-140.
60. Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, Kelly CP, Ahuja  V, Makharia GK. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 Mar 15. pii: S1542-3565(17)30783-8. doi: 10.1016/j.cgh.2017.06.037. [Epub ahead of print]
61. Singh P, Surana R, Soni S, Agnihotri A, Ahuja V, Makharia GK, Staller K, Kuo B. Cross cultural comparison of constipation profiles at tertiary care centers between India and USA. NeurogastroenterolMotil. 2018 Mar 9. doi: 10.1111/nmo.13324. [Epub ahead of print]
62. Tiwari V, Kedia S, Garg SK, Rampal R, Mouli VP, Purwar A, MitraDK,….. Ahuja V. CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease. PLoS One. 2018;13:e0193433.
63. Pratap Mouli V, Kedia S, Ahuja V. Letter: mucosal response in discriminating intestinal tuberculosis from Crohn's disease-when to look for it? Authors' reply. Aliment PharmacolTher. 2018;47:860-861.
64. Jain S, Kedia S, Bopanna S, Yadav DP, Goyal S, Sahni P, …. Ahuja V. Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study. Intest Res. 2018;16:69-74.
65. Singh S, Bhargava B, Vasantha P, Bhatia R, Sharma H, Pal S, Sahni P, Makharia GK. Clinical Evaluation of a Novel Intrarectal Device for Management of Fecal Incontinence in Bedridden Patients. J Wound Ostomy Continence Nurs. 2018;45:156-162.
66. Ramachandran A, Sharma S, Shalimar, Sharma R, Madhusudhan KS. Pancreatic walled-off necrosis eroding into the inferior vena cava. CurrProbl Diagn Radiol. 2018 Feb 2. pii: S0363-0188(18)30001-X. doi: 10.1067/j.cpradiol.2018.01.007. [Epub ahead of print].
67. Gupta S, Rout G, Patel AH, Mahanta M, Kalra N, Sahu P, Sethia R, Agarwal A, Ranjan G, Kedia S, Acharya SK, Nayak B, Shalimar. Efficacy of generic oral directly acting agents in patients with hepatitis C virus infection. J Viral Hepat. 2018 Jan 28. doi: 10.1111/jvh.12870. [Epub ahead of print] PubMed PMID: 29377464.
68. Subramani C, Nair VP, Anang S, Mandal SD, Pareek M, Kaushik N, Srivastava A, Saha S, Shalimar, Nayak B, Ranjith-Kumar CT, Surjit M. Host-Virus Protein Interaction Network Reveals the Involvement of Multiple Host Processes in the Life Cycle of Hepatitis E Virus. mSystems. 2018 Jan 23;3(1). pii: e00135-17.
69. Sonika U, Jadaun S, Ranjan G, Rout G, Gunjan D, Kedia S, Nayak B, Shalimar. Alcohol-related acute-on-chronic liver failure-Comparison of various prognostic scores in predicting outcome. Indian J Gastroenterol. 2018 Jan;37(1):50-57.
70. Garg H, Aggarwal S, Shalimar, Yadav R, Datta Gupta S, Agarwal L, Agarwal S. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. SurgObesRelat Dis. 2018;14:81-91.
71. Gyanranjan Rout, Saurabh Kedia, Baibaswata Nayak, Rajni Yadav, Prasenjit Das, Subrat K. Acharya , Deepak Gunjan, et al. Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients. J ClinExpHepatol2018;XX:1–9.
72. Sonika U, Jadaun S, Ranjan G, Rout G, Gunjan D, Kedia S, et al. Alcohol-related acute-on-chronic liver failure-Comparison of various prognostic scores in predicting outcome. Indian J Gastroenterol 2018;37:50–57.
73. Gunjan D, Gamanagatti S, Garg P. Endoscopic ultrasonography-guided obliteration of a left inferior phrenic artery pseudoaneurysm in a patient with alcoholic chronic pancreatitis. Endoscopy. 2018 Jan 19. doi: 10.1055/s-0043-124867.
74. Gunjan D, Jain S, Garg P. Dislodged hood stuck in submucosal tunnel: retrieval during peroral endoscopic myotomy. Endoscopy 2018; 50(11): 314 - 315. doi:10.1055/a-0658-0955.

 

List of publications during the year 2018-19

 

 

 

1. Moka P, Goswami P, Kapil A, Xess I, Sreenivas V, Saraya A. Impact of Antibiotic-Resistant Bacterial and Fungal Infections in Outcome of Acute Pancreatitis. Pancreas. 2018;47:489-494. 
2. Gupta P, Parshad R, Balakrishna P, Saraya A, Makharia GK, Sachdeva S, Sharma R. Angle of his accentuation is a viable alternative to dor fundoplication as an adjunct to laparoscopic Heller cardiomyotomy: results of a randomized clinical study. Digestive Diseases and Sciences. 2018;63:2395-404.  
3. Jain S, Mahapatra SJ, Gupta S, Shalimar, Garg PK. Infected Pancreatic Necrosis due to Multidrug-Resistant Organisms and Persistent Organ failure Predict Mortality in Acute Pancreatitis. Clin Transl Gastroenterol. 2018;9:190.  
4. Guda NM, Muddana V, Whitcomb DC, Levy P, Garg P, Cote G, Uc A, Varadarajulu S, Vege SS, Chari ST, Forsmark CE. Recurrent acute pancreatitis: international state-of-the-science conference with recommendations. Pancreas. 2018;47:653-66. 
5. Whitcomb DC, Shimosegawa T, Chari ST, Forsmark CE, Frulloni L, Garg P, Hegyi P, Hirooka Y, Irisawa A, Ishikawa T, Isaji S. International consensus statements on early chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with The International Association of Pancreatology, American Pancreatic Association, Japan Pancreas Society, Pancreas Fest Working Group and European Pancreatic Club. Pancreatology. 2018;18:516-27. 
6. Jain S, Midha S, Mahapatra SJ, Gupta S, Sharma MK, Nayak B, Jacob TG, Garg PK. Interleukin-6 significantly improves predictive value of systemic inflammatory response syndrome for predicting severe acute pancreatitis. Pancreatology. 2018;18:500-6.
7. Gupta V, Kedia S, Sonika U, Madhusudhan KS, Pal S, Garg P. A case of pancreatic AV malformation in an elderly man. Clin J Gastroenterol 2018;11:212-216.
8. Drewes AM, Campbell CM, Ceyhan GO, Delhaye M, Garg PK et al.  Pain in Pancreatic Ductal Adenocarcinoma: A Multidisciplinary, International Guideline for Optimized Management. Pancreatology 2018;18:446-457.
9. Yavvari PS, Verma P, Mustfa SA, Pal S, Kumar S, Awasthi AK, Ahuja V, Srikanth CV, Srivastava A, Bajaj A. A nanogel based oral gene delivery system targeting SUMOylation machinery to combat gut inflammation. Nanoscale. 2019;11:4970-86. 
10. Kedia S, Das P, Madhusudhan KS, Dattagupta S, Sharma R, Sahni P, MakhariaG,Ahuja V. Differentiating Crohn's disease from intestinal tuberculosis. World J Gastroenterol. 2019;25:418-432.  
11. Kamat N, Kedia S, Ghoshal UC, Nehra A, Makharia G, Sood A, Midha V, Gupta V, Choudhuri G, Ahuja V. Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study. Indian J Gastroenterol. 2019;38:44-54. 
12. Jain S, Ahuja V, Limdi JK. Optimal management of acute severe ulcerative colitis. Postgrad Med J. 2019 ;95:32-40. 
13. Shah D, Makharia GK, Ghoshal UC, Varma S, Ahuja V, Hutfless S. Burden of gastrointestinal and liver diseases in India, 1990-2016. Indian J Gastroenterol. 2018 ;37:439-445. 
14. Agarwal A, Kedia S, Jain S, Gupta V, Bopanna S, Yadav DP, Goyal S, MouliVP,  Dhingra R, Makharia G, Ahuja V. High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India. Intest Res. 2018;16:588-598. 
15. Das P, Rampal R, Udinia S, Kumar T, Pilli S, Wari N, Ahmed IK, Kedia S, Gupta SD, Kumar D, Ahuja V. Selective M1 macrophage polarization in granuloma-positive and granuloma-negative Crohn's disease, in comparison to intestinal tuberculosis. Intest Res. 2018;16:426-435 
16. Bag S, Ghosh TS, Banerjee S, Mehta O, Verma J, Dayal M, Desigamani A, Kumar P, Saha B, Kedia S, Ahuja V, Ramamurthy T, Das B. Molecular Insights into Antimicrobial Resistance Traits of Commensal Human Gut Microbiota. Microb Ecol. 2019;77:546-557.
17. Das B, Ghosh TS, Kedia S, Rampal R, Saxena S, Bag S, Mitra R, Dayal M, Mehta  O, Surendranath A, Travis SPL, Tripathi P, Nair GB, Ahuja V. Analysis of the Gut Microbiome of Rural and Urban Healthy Indians Living in Sea Level and High Altitude Areas. Sci Rep. 2018;8:10104.  
18. Kedia S, Ahuja V. Is the emergence of inflammatory bowel disease a prime example of "the third epidemiological transition"? Indian J Gastroenterol. 2018;37:183-185. 
19. Kedia S, Jain S, Goyal S, Bopanna S, Yadav DP, Sachdev V, Sahni P, Pal S, Dash NR, Makharia G, Travis SPL, Ahuja V. Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe Disease. Dig Dis Sci. 2018 ;63:2747-2753. 
20. Aggarwal S, Ahuja V, Paul J. Dysregulation of GABAergic Signaling Contributes in the Pathogenesis of Diarrhea-predominant Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2018;24:422-430. 
21. Kedia S, Limdi JK, Ahuja V. Management of inflammatory bowel disease in older persons: evolving paradigms. Intest Res. 2018;16:194-208. 
22. Arora U, Kedia S, Garg P, Bopanna S, Jain S, Yadav DP, Goyal S, Gupta V, Sahni P, Pal S, Dash NR, Madhusudhan KS, Sharma R, Makharia G, Ahuja V. Colonic Crohn's Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic Disease. Dig Dis Sci. 2018;63:1592-1599. 
23. Kedia S, Madhusudhan KS, Sharma R, Bopanna S, Yadav DP, Goyal S, Jain S, Das P, Dattagupta S, Makharia G, Ahuja V. Combination of increased visceral fat and long segment involvement: Development and validation of an updated imaging marker for differentiating Crohn's disease from intestinal tuberculosis. J Gastroenterol Hepatol. 2018;33:1234-1241 
24. Singh P, Surana R, Soni S, Agnihotri A, Ahuja V, Makharia GK, Staller K, Kuo B. Cross cultural comparison of constipation profiles at tertiary care centers between India and USA. Neurogastroenterology & Motility. 2018;30:e13324. 
25. Singh S, Bhargava B, Vasantha P, Bhatia R, Sharma H, Pal S, Sahni P, Makharia GK. Clinical Evaluation of a Novel Intrarectal Device for Management of Fecal Incontinence in Bedridden Patients. J Wound Ostomy Continence Nurs. 2018;45:156-162. 
26. Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, Kelly CP, Ahuja V, Makharia GK. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018;16:823-836. 
27. Kinra P, Gahlot GPS, Yadav R, Baloda V, Makharia GK, Gupta SD, Das P.Histological assessment & use of immunohistochemical markers for detection ofdysplasia in Barrett's esophageal mucosa. Pathol Res Pract. 2018;214:993-999. 
28. Das P, Gahlot GP, Singh A, Baloda V, Rawat R, Verma AK, Khanna G, Roy M,George A, Singh A, Nalwa A, Ramteke P, Yadav R, Ahuja V, Sreenivas V, Gupta SD, Makharia GK. Quantitative histology-based classification system for assessment ofthe intestinal mucosal histological changes in patients with celiac disease. Intest Res. 2019. doi: 10.5217/ir.2018.00167. 
29. Bodkhe R, Shetty SA, Dhotre DP, Verma AK, Bhatia K, Mishra A, Kaur G, Pande P, Bangarusamy DK, Santosh BP, Perumal RC, Ahuja V, Shouche YS, Makharia GK. Comparison of Small Gut and Whole Gut Microbiota of First-Degree Relatives With Adult Celiac Disease Patients and Controls. Front Microbiol. 2019;10:164. 
30. Makharia GK, Catassi C. Celiac Disease in Asia. Gastroenterol Clin North Am.2019;48:101-113. 
31. Lindfors K, Ciacci C, Kurppa K, Lundin KEA, Makharia GK, Mearin ML, Murray JA,Verdu EF, Kaukinen K. Coeliac disease. Nat Rev Dis Primers. 2019;5:3. 
32. Verma AK, Singh A, Gatti S, Lionetti E, Galeazzi T, Monachesi C, Franceschini E, Ahuja V, Catassi C, Makharia GK. Validation of a novel single-drop rapid human leukocyte antigen-DQ2/-DQ8 typing method to identify subjects susceptible to celiac disease. JGH Open. 2018;2:311-316. 
33. Singh P, Makharia GK. Reply. Clin Gastroenterol Hepatol. 2018;16:2003. 
34. Mehtab W, Singh N, Malhotra A, Makharia GK. All that a physician should know about gluten-free diet. Indian J Gastroenterol. 2018;37:392-401. 
35. Samal P, Goyal V, Makharia GK, Das CJ, Gorthi SP, Y VV, Singh MB, Srivastava MVP. Transfer Dysphagia Due to Focal Dystonia. J Mov Disord. 2018;11:129-132. 
36. Sharma P, Baloda V, Gahlot GP, Singh A, Mehta R, Vishnubathla S, Kapoor K,Ahuja V, Gupta SD, Makharia GK, Das P. Clinical, endoscopic, and histological differentiation between celiac disease and tropical sprue: A systematic review. J Gastroenterol Hepatol. 2019;34:74-83. 
37. Acharya P, Kutum R, Pandey R, Mishra A, Saha R, Munjal A, Ahuja V, Mukerji M,Makharia GK. First Degree Relatives of Patients with Celiac Disease Harbour an Intestinal Transcriptomic Signature that Might Protect them from Enterocyte Damage. Clin Transl Gastroenterol. 2018;9:195.
38. Singh P, Arora A, Strand TA, Leffler DA, Mäki M, Kelly CP, Ahuja V, Makharia GK. Diagnostic Accuracy of Point of Care Tests for Diagnosing Celiac Disease: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2018 Jun 16. Doi.10.1097/MCG.0000000000001081. 
39. Shalimar, Sonika U, Kedia S, Mahapatra SJ, Nayak B, Yadav DP, Gunjan D, Thakur B, Kaur H, Acharya SK. Comparison of Dynamic Changes Among Various Prognostic Scores in Viral Hepatitis-Related Acute Liver Failure. Ann Hepatol. 2018 ;17:403-412. 
40. Haffar S, Shalimar, Kaur RJ, Wang Z, Prokop LJ, Murad MH, Bazerbachi F. Acute liver failure caused by hepatitis E virus genotype 3 and 4: A systematic review and pooled analysis. Liver Int. 2018;38:1965-1973. 
41. Agarwal K, Brunetto M, Seto WK, Lim YS, Fung S, Marcellin P, Ahn SH, Izumi N, Chuang WL, Bae H, Sharma M, Janssen HLA, Pan CQ, Çelen MK, Furusyo N, Shalimar D,Yoon KT, Trinh H, Flaherty JF, Gaggar A, Lau AH, Cathcart AL, Lin L, Bhardwaj N, Suri V, Mani Subramanian G, Gane EJ, Buti M, Chan HLY; GS-US-320-0110;GS-US-320-0108 Investigators. 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. J Hepatol. 2018;68:672-681. 
42. Madhusudhan KS, Kilambi R, Shalimar, Sahni P, Sharma R, Srivastava DN, Gupta AK. Measurement of splenic stiffness by 2D-shear wave elastography in patients with extra hepatic portal vein obstruction. Br J Radiol. 2018;91:20180401. 
43. Shalimar, Sheikh MF, Mookerjee RP, Agarwal B, Acharya SK, Jalan R. Prognostic Role of Ammonia in Cirrhotic Patients. Hepatology. 2019. doi:10.1002/hep.30534. 
44. Shalimar, Rout G, Jadaun SS, Ranjan G, Kedia S, Gunjan D, Nayak B, Acharya SK,Kumar A, Kapil A. Prevalence, predictors and impact of bacterial infection in acute on chronic liver failure patients. Dig Liver Dis. 2018; 50:1225-1231. 
45. Kim JD, Cho EJ, Ahn C, Park SK, Choi JY, Lee HC, Kim DY, Choi MS, Wang HJ, Kim IH, Yeon JE, Seo YS, Tak WY, Kim MY, Lee HJ, Kim YS, Jun DW, Sohn JH, Kwon SY,Park SH, Heo J, Jeong SH, Lee JH, Nakayama N, Mochida S, Ido A, Tsubouchi H, Takikawa H, Shalimar, Acharya SK, Bernal W, O'Grady J, Kim YJ. A Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure. Hepatology. 2018 doi: 10.1002/hep.30262. 
46. Cathcart AL, Chan HL, Bhardwaj N, Liu Y, Marcellin P, Pan CQ, Shalimar, Buti M, Cox S, Parhy B, Zhou E, Martin R, Chang S, Lin L, Flaherty JF, Kitrinos KM, Gaggar A, Izumi N, Lim YS. No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection. Antimicrob Agents Chemother. 2018 24;62. 
47. Kilambi R, Singh AN, Madhusudhan KS, Pal S, Saxena R, Shalimar, Dash NR, Sahni P. Portal hypertension and hypersplenism in extrahepatic portal venous obstruction: Are they related? Indian J Gastroenterol. 2018;37:202-208. 
48. Sood A, Duseja A, Kabrawala M, Amrose P, Goswami B, Chowdhury A, Sarin SK,Koshy A, Hyland RH, Lu S, Camus G, Stamm LM, Brainard DM, Subramanian GM, Prasad M, Bhatia S, Shah SR, Kapoor D, Shalimar, Saraswat V. Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India. Hepatol Int. 2019. doi: 10.1007/s12072-019-09927-6 
49. Rout G, Kedia S, Nayak B, Yadav R, Das P, Acharya SK, Gunjan D, Singh V,Mahanta M, Gupta S, Aggarwal S, Shalimar. Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients. J Clin Exp Hepatol. 2019;9:13-21. 
50. Gupta S, Rout G, Patel AH, Mahanta M, Kalra N, Sahu P, Sethia R, Agarwal A, Ranjan G, Kedia S, Acharya SK, Nayak B, Shalimar. Efficacy of generic oral directly acting agents in patients with hepatitis C virus infection. J Viral Hepat. 2018;25:771-778. 
51. Madhusudhan KS, Kilambi R, Shalimar, Pal S, Sharma R, Srivastava DN. Evaluation of Splenic Stiffness in Patients of Extrahepatic Portal Vein Obstruction Using 2D Shear Wave Elastography: Comparison with Intra-Operative Portal Pressure. J Clin Exp Hepatol. 2018;8:250-255. 
52. Anang S, Kaushik N, Hingane S, Kumari A, Gupta J, Asthana S, Shalimar, Nayak B, Ranjith-Kumar CT, Surjit M. Potent Inhibition of Hepatitis E Virus Release by a Cyclic Peptide Inhibitor of the Interaction between Viral Open Reading Frame 3 Protein and Host Tumor Susceptibility Gene 101. J Virol. 2018;92. pii: e00684-18. 
53. Dubasi SK, Ranjan P, Arora C, Vikram NK, Dwivedi SN, Singh N, Kaloiya GS, Shalimar. Questionnaire to assess adherence to diet and exercise advices for weight management in lifestyle-related diseases. J Family Med Prim Care. 2019;8:689-694. 
54. Kumar A, Shalimar, Walia GK, Gupta V, Sachdeva MP. Genetics of nonalcoholic fatty liver disease in Asian populations. J Genet. 2019 ;98. pii: 31.
55. Arora P, Jadaun SS, Das P, Shalimar, Datta SK. Unusually Low Serum Alkaline Phosphatase Activity in a Patient with Acute on Chronic Liver Failure and Hemolysis. EJIFCC. 2019;30:99-105. 
56. Rout G, Shalimar, Gunjan D, Mahapatra SJ, Kedia S, Garg PK, Nayak B. Thromboelastography-guided Blood Product Transfusion in Cirrhosis Patients With Variceal Bleeding: A Randomized Controlled Trial. J Clin Gastroenterol. 2019. doi: 10.1097/MCG.0000000000001214. 
57. Rout G, Nayak B, Patel AH, Gunjan D, Singh V, Kedia S, Shalimar. Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography. J Clin Exp Hepatol. 2019 ;9:207-214. 
58. Nayak B, Nongthombam S, Roy N, Nadda N, Mondol K, Kumar V, Das P, Vanamail P, Shalimar D, Acharya SK. Hepatic and Systemic Effect of Non-Alcoholic Fatty Liver Disease Severity in Obese and Non-Obese Indian Patients. Int Gast Hepatol, 2019;1: 81-91. 
59. Goyal S, Jadaun S, Kedia S, Acharya SK, Varma S, Nayak B, Thakur B, Shalimar. Thromboelastography Parameters in Patients with Acute on Chronic Liver Failure. Ann Hepatol. 2018 16;17:1042-1051. 
60. Rani D, Saxena R, Nayak B, Srivastava S. Cloning and expression of truncated ORF2 as a vaccine candidate against hepatitis E virus. 3 Biotech. 2018;8:414 
61. Gupta S, Rawat S, Arora V, Kottarath SK, Dinda AK, Vaishnav PK, Nayak B, Mohanty S. An improvised one-step sucrose cushion ultracentrifugation method for exosome isolation from culture supernatants of mesenchymal stem cells. Stem Cell Res Ther. 2018;9:180. 
62. Shalimar, Jain S, Gamanagatti SR, Kedia S, Thakur B, Nayak B, Kaur H, Gunjan D, Paul SB, Acharya SK. Role of Indocyanine Green in Predicting Post-Transarterial Chemoembolization Liver Failure in Hepatocellular Carcinoma. J Clin Exp Hepatol. 2018;8:28-34 
63. Shalimar, Sonika U, Kedia S, Mahapatra SJ, Nayak B, Yadav DP, Gunjan D, Thakur B, Kaur H, Acharya SK. Comparison of Dynamic Changes Among Various Prognostic Scores in Viral Hepatitis-Related Acute Liver Failure. Ann Hepatol. 2018;17:403-412. 
64. Kedia S, Ahuja V. Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East. Inflamm Intest Dis. 2017 Nov;2(2):102-115. doi: 10.1159/000465522. Epub 2017 8. Review. 
65. Jain S, Kedia S, Bopanna S, Yadav DP, Goyal S, Sahni P, Dash NR, Pal S, Makharia G, Ahuja V. Left-sided colitis and extensive colitis have similar colectomy rates after index episode of acute severe colitis: A long-term follow-up study. JGH Open. 2017 28;1:134-139. 
66. Singh K R, Muktesh G, Gunjan D, Kochhar R , Singh V, Das A, Siddappa P, Singh K. Patterns of alcohol consumption and nutrition intake in patients with alcoholic liver disease and alcoholic pancreatitis in North Indian men. JGH Open 2019. doi:10.1002/jgh3.12165 
67. 67.  Gunjan D, Jain S, Garg P. Dislodged hood stuck in submucosal tunnel: retrieval during per oral endoscopic myotomy. Endoscopy. 2018;50:E314-E315. 
68. 68.  Gunjan D, Sharma V. Acute Pancreatitis as a Precipitant of Acute-on-chronic Liver Failure in a Patient with Underlying Hepatitis C-related Cirrhosis. J Gastrointest Infect 2018;8:46-47.

List of publications during the year 2019-20

1. Singh N, Rashid S, Rashid S, Dash NR, Gupta S, Saraya A. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients. J Cancer Res Clin Oncol. 2020;146(4):897‐907
2. Agarwal S, Sharma S, Gunjan D, Singh N, Kaushal K, Poudel S, ----, Saraya A. Natural course of chronic pancreatitis and predictors of its progression. Pancreatology. 2020;20(3):347‐355. 
3. Khetan K, Baloda V, Sahoo RK, Vishnubhathla S, Yadav R, Saraya A, et al. SPARC expression in desmoplastic and non-desmoplastic pancreatic carcinoma and cholangiocarcinoma. Pathol Res Pract. 2019;215:152685. 
4. Sarin SK, Choudhury et al. AAARC for APASL ACLF working Party. Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:826-828. 
5. Singh N, Sonika U, Moka P, Sharma B, Sachdev V, Mishra SK, -- Saraya A. Association of endotoxaemia & gut permeability with complications of acute pancreatitis: Secondary analysis of data. IJMR. 2019;149:763-770. 
6. Sarin SK, Choudhury A et al. APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353-390. 
7. Pant K, Mishra AK, Pradhan SM, Nayak B, Das P, Shalimar, et al. Butyrate inhibits HBV replication and HBV-induced hepatoma cell proliferation via modulating SIRT-1/Ac-p53 regulatory axis. Mol Carcinog. 2019;58:524-532 
8. Singh N, Ahuja V, Sachdev V, Upadhyay AD, Goswami R, Ramakrishnan L, --- Saraya A. Antioxidants for Pancreatic Functions in Chronic Pancreatitis: A Double-blind Randomized Placebo-controlled Pilot Study. J Clin Gastroenterol. 2020;54:284-293. 
9. Iyer H, Elhence A, Mittal S, Madan K, Garg PK. Pulmonary complications of acute pancreatitis. Expert Rev Respir Med. 2020;14:209‐17. 
10. Jain S, Padhan R, Bopanna S, et al. Percutaneous Endoscopic Step-Up Therapy Is an Effective Minimally Invasive Approach for Infected Necrotizing Pancreatitis. Dig Dis Sci. 2020;65:615‐622. 
11. Singh VK, Yadav D, Garg PK. Diagnosis and management of chronic pancreatitis: A Review. JAMA 2019;322:2422-34.  
12. Madhusudhan KS, Das P, Gunjan D, Srivastava DN, Garg PK. IgG4-Related Sclerosing Cholangitis: A Clinical and Imaging Review. AJR Am J Roentgenol. 2019;213:1221-1231. 
13. Garg PK, Meena D, Babu D, et al. Endoscopic versus laparoscopic drainage of pseudocyst and walled-off necrosis following acute pancreatitis: a randomized trial. Surg Endosc. 2020;34:1157‐1166.
14. Garg PK. Annals for Hospitalists Inpatient Notes - Clinical Pearls-Acute Pancreatitis. Ann Intern Med. 2019 Feb 19;170(4):HO2-HO3. 
15. Garg PK, Zyromski NJ, Freeman ML. Infected Necrotizing Pancreatitis: Evolving Interventional Strategies from Minimally Invasive Surgery to Endoscopic Therapy-Evidence Mounts, But One Size Does Not Fit All. Gastroenterology. 2019,156:867-71. 
16. Garg PK, Singh VP. Organ Failure due to systemic injury in acute pancreatitis. Gastroenterology. 2019;156:2008-2023. 
17. Mahapatra SJ, Jain S, Bopanna S, Gupta S, Singh P, Trikha A, Sreenivas V, Shalimar, Garg PK. Pentazocine, a kappa-opioid agonist, is better than diclofenac for analgesia in acute pancreatitis: a randomized controlled trial. Am J Gastroenterol. 2019;114:813-21.
18. Kedia S, Sharma R, Makharia G, Ahuja V, Desai D, Kandasamy D, et al. Indian guidelines on imaging of the small intestine in Crohn's disease: A joint Indian Society of Gastroenterology and Indian Radiology and Imaging Association consensus statement. Indian J Radiol Imaging. 2019;29:111-132.  
19. Sood A, Ahuja V, Kedia S, Midha V, Mahajan R, Mehta V et al.  Diet and inflammatory bowel disease: The Asian Working Group guidelines. Indian J Gastroenterol.2019;38:220-246.  
20. Ooi CJ, Hilmi I, Banerjee R, Chuah SW, Ng SC, Wei SC, Makharia GK, etal.; Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn’s and Colitis. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia. Intest Res. 2019;17:285-310.  
21. Ooi CJ, Hilmi I, Banerjee R, Chuah SW, Ng SC, Wei SC, Makharia GK, et al.; Asia-Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn's and Colitis. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia. J Gastroenterol Hepatol. 2019 ;34:1296-1315.  
22. Mathur P, Sharma R, Kandasamy D, Kedia S, Gamanagatti S, Ahuja V. Can ADC be used as a surrogate marker of response to therapy in intestinal tuberculosis? Abdom Radiol (NY). 2019;44:3006-3018.  
23. Suhail A, Rizvi ZA, Mujagond P, Ali SA, Gaur P, Singh M, Ahuja V, et al..  DeSUMOylase SENP7-Mediated Epithelial Signaling Triggers Intestinal Inflammation via Expansion of Gamma-Delta T Cells. Cell Rep. 2019 10;29:3522-3538.e7.  
24. Mak JWY, Tang W, Yip TCF, Ran ZH, Wei SC, Ahuja V, et al. Stopping anti-tumour necrosis factor therapy in patients with perianal Crohn's disease. Aliment Pharmacol Ther. 2019;50:1195-1203.  
25. Valmiki S, Ahuja V, Puri N, Paul J. miR-125b and miR-223 Contribute to Inflammation by Targeting the Key Molecules of NFκB Pathway. Front Med (Lausanne). 2020;6:313.  
26. Laube R, Yau Y, Selinger CP, Seow CH, Thomas A, Wei Chuah S, ----,Ahuja V, et al. Knowledge and attitudes towards pregnancy in females with Inflammatory Bowel Disease - an international, multi-centre study. J Crohns Colitis. 2020 Mar 11. pii: jjaa047.  
27. Kedia S, Mouli VP, Kamat N, Sankar J, Ananthakrishnan A, Makharia G, Ahuja V. Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2020;115:340-349.  
28. Kaur P, Agarwala A, Makharia G, Bhatnagar S, Tandon N. Effect of gluten free Diet on metabolic control and anthropometric parameters in type 1 diabetes with Subclinical celiac disease: a randomized controlled trial. Endocr Pract. 2020 Mar11. doi: 10.4158/EP-2019-0479. [Epub ahead of print]  
29. Gupta V, Singh A, Khadgawat R, Agarwal A, Iqbal A, Mehtab W, ---, Makharia GK. The spectrum of clinical and subclinical endocrinopathies in treatment-naïve patients with celiac disease. Indian J Gastroenterol. 2019;38:518-526.  
30. Mehtab W, Agarwal A, Singh N, Malhotra A, Makharia GK. All that a physician should know about FODMAPs. Indian J Gastroenterol. 2019;38:378-390.  
31. Soni S, Agarwal A, Singh A, Gupta V, Khadgawat R, Chaturvedi PK, Ahuja V, Makharia GK. Prevalence of thyroid autoimmunity in first-degree relatives of patients with celiac disease. Indian J Gastroenterol. 2019;38:450-455.  
32. Singh P, Singh A, Silvester JA, Sachdeva V, Chen X, ---, Makharia GK. Inter- and Intra-assay Variation in the Diagnostic Performance of Assays for Anti-tissue Transglutaminase in 2 Populations. Clin Gastroenterol Hepatol. 2019 Sep 20. pii: S1542-3565(19)31023-7.  
33. Singh A, Verma AK, Das P, Prakash S, Pramanik R, Nayak B, ---, Makharia GK. Non-immunological biomarkers for assessment of villous abnormalities in patients with celiac disease. J Gastroenterol Hepatol. 2020;35:438-445.  
34. Bhatia SJ, Makharia GK, Abraham P, Bhat N, Kumar A, Reddy DN, et al. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019;38:411-440.  
35. S Gahlot GP, Das P, Baloda V, Singh A, Vishnubhatla S, Gupta SD, Makharia GK. Duodenal mucosal immune cells in treatment-naive adult patients with celiac disease having different histological grades and controls. Indian J Pathol Microbiol. 2019;62:399-404.  
36. Dhawan A, Agarwal A, Mulder CJ, Makharia GK. Celiac disease in the East and the West: Bridging the gaps between the guidelines and their implementation in daily practice is mandatory. Indian J Gastroenterol. 2019;38:185-189.  
37. Singh A, Pramanik A, Acharya P, Makharia GK. Non-Invasive Biomarkers for Celiac Disease. J Clin Med. 2019;8:885  
38. Yoosuf S, Makharia GK. Evolving Therapy for Celiac Disease. Front Pediatr. 2019;7:193.  
39. Das P, Gahlot GP, Singh A, Baloda V, Rawat R, Verma AK, et al. Quantitative histology-based classification system for assessment of the intestinal mucosal histological changes in patients with celiac disease. Intest Res. 2019;17:387-397.  
40. Singh P, Arora A, Strand TA, Leffler DA, Mäki M, Kelly CP, -, Makharia  GK. Diagnostic Accuracy of Point of Care Tests for Diagnosing Celiac Disease: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2019;53:535-542.  
41. Das Prasenjit, Makharia GK, Just do not stop at colonoscopy, Do biopsies (Editorial). J Dig Endosc 2019;10:03-05  
42. Shalimar, Kumar R, Rout G, Kumar R, Yadav R, Das P, et al. Body mass index-based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease. Indian J Gastroenterol. 2020 Mar 17. doi: 10.1007/s12664-019-00991-2. [Epub ahead of print] PubMed PMID: 32185692.  
43. Elhence A, Shalimar. Treatment of non-alcoholic fatty liver disease - Current perspectives. Indian J Gastroenterol. 2020 Mar 9. doi:10.1007/s12664-020-01021-2. [Epub ahead of print] Review. PubMed PMID: 32152902.  
44. Singh AD, Maitra S, Singh N, Tyagi P, Ashraf A, Kumar R, Shalimar. Systematic review with meta-analysis: impact of baseline resistance-associated substitutions on the efficacy of glecaprevir/pibrentasvir among chronic hepatitis C patients. Aliment Pharmacol Ther. 2020;51:490-504.  
45. Shalimar, Sharma S, Gamanagatti SR, Chauhan A, Vuyyuru SK, Elhence A, et al.. Acute-on-Chronic Liver Failure in Budd-Chiari Syndrome: Profile and Predictors of Outcome. Dig Dis Sci. 2020 Jan2.doi: 10.1007/s10620-019-06005-7. [Epub ahead of print] PubMed PMID: 31897895.  
46. Vuyyuru SK, Singh AD, Gamanagatti SR, Rout G, Gunjan D, Shalimar. A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures. Dig Dis Sci. 2019 Nov 13. doi: 10.1007/s10620-019-05939-2. [Epub ahead of print] PubMed PMID: 31720889.  
47. Sharma S, Kumar R, Rout G, Gamanagatti SR, Shalimar. Dabigatran as an oral anticoagulant in patients with Budd-Chiari syndrome post-percutaneous endovascular intervention. J Gastroenterol Hepatol. J Gastroenterol Hepatol. 2020;35:654‐662  
48. Rout G, Sharma S, Gunjan D, Kedia S, Nayak B, Shalimar. Comparison of various prognostic scores in variceal and non-variceal upper gastrointestinal bleeding: A prospective cohort study. Indian J Gastroenterol. 2019;38:158-166.  
49. Rout G, Sharma S, Gunjan D, Kedia S, Saraya A, Nayak B, et al. Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding. Dig Dis Sci. 2019;64:2327-2337.  
50. Shalimar, Sheikh MF, Mookerjee RP, Agarwal B, Acharya SK, Jalan R. Prognostic Role of Ammonia in Patients With Cirrhosis. Hepatology. 2019;70:982-994.  
51. Paul SB, Sahu P, Sreenivas V, Nadda N, Gamanagatti SR, Nayak B, Shalimar S, Acharya SK. Prognostic role of serial alpha-fetoprotein levels in hepatocellular  carcinoma treated with locoregional therapy. Scand J Gastroenterol. 2019 ;54:1132-1137.  
52. Gupta J, Kaul S, Srivastava A, Kaushik N, Ghosh S, Sharma C, Batra G,et al. Expression, purification and characterization of the Hepatitis E virus like-particles expressed in the Pichia pastoris. Front Microbiol. 2020;11:141.   
53. Roy N, Prasad C, Kumar A, Mondol K, Jain K, Yadav R, et al. Protective IFNL4 haplotype, linkage disequilibrium and their influence on virological response to Hepatitis C virus infection in Indian population.  Virus Dis. 2019;30:344‐353.   
54. Nayak B, Nongthombam S, Roy N, Nadda N, Mondol K, Kumar V, et al. Hepatic and Systemic Effect of Non-Alcoholic Fatty Liver Disease Severity in Obese and Non-Obese Indian Patients. Int Gast Hepatol, 2019; 1: 81-91.  
55. Tomar SK, Kedia S, Singh N, Upadhyay AD, Kamat N, Bopanna S, ----Vineet Ahuja. Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease. JGH Open. 2019;3:302-309.  
56. Agarwal A, Mahapatra SJ, Gunjan D. Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for prevention of post-ERCP pancreatitis: results are as yet inconclusive. Endoscopy. 2020;52:320. 

2021-22

1. Agarwal A, Sharma S, Saraya A. Letter to the Editor: Defining the Futility for Rescue Transjugular Intrahepatic Portosystemic Shunt Using the Model for End-Stage Liver Disease Score and Lactate in Variceal Bleed. Vol. 74, Hepatology (Baltimore, Md.). United States; 2021. p. 3556–7.

2. Agarwal N, Mahey R, Kulshrestha V, Kriplani A, Saraya A, Sachdev V. Serum Bile Acids in Intrahepatic Cholestasis of Pregnancy (ICP), Versus Pregnant  and Nonpregnant Controls in Asian Indian Women and a Proposed Scoring to Optimize Management in ICP. J ObstetGynaecol India. 2022 Jun;72(3):218–24.

3. Agarwal S, Sharma S, Jindal A, Singh S, Jagdish R, Gunjan D, et al. Application of Noninvasive Tools to Decide the Need for Beta-Blockers for  Variceal Bleeding Prophylaxis in Compensated Advanced Liver Disease: A Decision Curve Analysis. J Clin Exp Hepatol. 2022;12(3):917–26.

4. Agarwal S, Sharma S, Kumar M, Venishetty S, Bhardwaj A, Kaushal K, et al. Development of a machine learning model to predict bleed in esophageal varices in  compensated advanced chronic liver disease: A proof of concept. J Gastroenterol Hepatol. 2021 Oct;36(10):2935–42.

5. Anand A, Mohta S, Agarwal S, Sharma S, Gopi S, Gunjan D, et al. European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis. J Clin Exp Hepatol [Internet]. 2022 Jan 1 [cited 2022 Jan 30];12(1):52–60. Available from: https://pubmed.ncbi.nlm.nih.gov/35068785/

6. Anand A, Nambirajan A, Kumar V, Agarwal S, Sharma S, Mohta S, et al. Alterations in Autophagy and Mammalian Target of Rapamycin (mTOR) Pathways  Mediate Sarcopenia in Patients with Cirrhosis. J Clin Exp Hepatol. 2022;12(2):510–.

7. Anand A, Saraya A. Assessment of Sarcopenia in Chronic Liver Disease: Indian Perspective. Clin liver Dis. 2021 Sep;18(3):164–7.

8. Baloda V, Anand A, Yadav R, Mehra L, Rajeshwari M, Vishnubhatla S, et al. Histologic Changes in Core-Needle Liver Biopsies From Patients With  Acute-on-Chronic Liver Failure and Independent Histologic Predictors of 28-Day Mortality. Arch Pathol Lab Med. 2022 Jul;146(7):846–54.

9. Chauhan A, Madhu D, Sharma S, Saraya A. Fresh frozen plasma transfusion affects outcomes in acute variceal bleeding:  Right conclusion? Vol. 41, Liver international : official journal of the International Association for the  Study of the Liver. United States; 2021. p. 1976.

10. Grover I, Gunjan D, Singh N, Benjamin J, Ramakrishnan L, Pandey RM, et al. Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density  in Patients With Cirrhosis: A Randomized Clinical Trial. Am J Gastroenterol. 2021 Oct;116(10):2098–104.

11. Grover I, Gunjan D, Singh N, Saraya A. Response to Zhai and Tang. Vol. 116, The American journal of gastroenterology. United States; 2021. p. 2144.

12. Grover I, Gunjan D, Singh N, Saraya A. Response to Medda et al. Am J Gastroenterol. 2022 May;117(5):814.

13. Grover I, Singh N, Gunjan D, Pandey RM, Chandra Sati H, Saraya A. Comparison of Anthropometry, Bioelectrical Impedance, and Dual-energy X-ray  Absorptiometry for Body Composition in Cirrhosis. J Clin Exp Hepatol. 2022;12(2):467–74.

14. Jadaun SS, Sharma S, Madhusudhan KS, Sharma R, Nayak B, Kedia S, et al. Spectrum of Neuroimaging Abnormalities in Brain in Patients of Acute-on-Chronic  Liver Failure. J Clin Exp Hepatol. 2022;12(2):343–52.

15. Jagannath S, Agarwal A, Gunjan D, Mohindra S, Sharma V, Chowdhury SD, et al. Mandatory preprocedure testing for SARS-CoV-2 for all-comers may not be required  for resuming endoscopic services amidst the ongoing COVID-19 pandemic. Vol. 70, Gut. England; 2021. p. 1805–6.

16. Jindal A, Sharma S, Agarwal S, Kumar M, Saraya A, Sarin SK. Liver stiffness can predict decompensation and need for beta-blockers in  compensated cirrhosis: a step beyond Baveno-VI criteria. Hepatol Int. 2022 Feb;16(1):89–98.

17. Kaushal K, Gupta V, Goswami P, Agarwal S, Sharma S, Das P, et al. Acute Variceal Bleed in Cirrhosis is Associated With Reversible Changes in Tight  Junction Protein Expression in the Intestine: A Proof-of-Concept Study. J Clin Exp Hepatol. 2022;12(1):89–100.

18. Madhu D, Sharma S, Agarwal A, Saraya A. Special Considerations in the Management of Autoimmune Hepatitis in COVID-19  Hotspots: A Review. J Clin Transl Hepatol. 2021 Aug;9(4):568–75.

19. Mohta S, Sharma S, Saraya A. Decompensation in Patients With Nonalcoholic Steatohepatitis: A Multihit  Hypothesis. Clinical gastroenterology and hepatology : the official clinical practice journal  of the American Gastroenterological Association. United States; 2021.

20. Mohta S, Sharma S, Saraya A. Improvement in adipocytic indices as a predictor of improved outcomes after TIPS:  Right conclusion? Vol. 42, Liver international : official journal of the International Association for the  Study of the Liver. United States; 2022. p. 253.

21. Nayak B, Lal G, Kumar S, Das CJ, Saraya A, Shalimar. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and  Gastrointestinal Diseases. Front Cell Infect Microbiol. 2021;11:753249.

22. Sharma S, Chauhan A, Saraya A. Prediction of post TIPS hepatic encephalopathy: are we there yet? Vol. 15, Hepatology international. United States; 2021. p. 1027.

23. Sharma S, Gunjan D, Saraya A. Letter to the Editor: Balloon-Occluded Retrograde Transvenous Obliteration for  Prevention of Gastric Variceal Rebleeding: A Paradigm Shift? Vol. 74, Hepatology (Baltimore, Md.). United States; 2021. p. 1721–2.

24. Sharma S, Saraya A. Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated  Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet? Vol. 116, The American journal of gastroenterology. United States; 2021. p. 1756.

25. Sharma S, Yegurla J, Singh N, Gunjan D, Saraya A. Duration of Fasting During Acute Variceal Bleeding in Chronic Liver Disease:  Perceptions and Practices of Gastroenterologists. J Clin Exp Hepatol. 2021;11(6):753–5.

26. Suyal G, Pandey P, Saraya A, Sharma R. Tumour suppressor role of microRNA-335-5p in esophageal squamous cell carcinoma  by targeting TTK (Mps1). Exp Mol Pathol. 2022 Feb;124:104738.

27. Caron B, Abreu MT, Siegel CA, Panaccione R, Sands BE, Dignass A et al. IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus. Clin Gastroenterol Hepatol. 2022:S1542-3565(22)00188-4.

28. Vuyyuru SK, Kedia S, Sahu P, Ahuja V. Immune-mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis. JGH Open. 2022 Jan 20;6(2):100-111. doi: 10.1002/jgh3.12706. PMID: 35155819; PMCID: PMC8829105.

29. Guillo L, Abreu M, Panaccione R, Sandborn WJ, Azevedo VF, Gensler L et al. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):254-261. doi: 10.1016/S2468-1253(21)00297-1. Epub 2022 Jan 17. PMID: 35051383.

30. Gupta S, Mishra DK, Khan MZ, Saini V, Mehta D, Kumar S et al. Development of a Highly Specific, Selective, and Sensitive Fluorescent Probe for Detection of Mycobacteria in Human Tissues. Adv Healthc Mater. 2022 Jan 17:e2102640. doi: 10.1002/adhm.202102640. Epub ahead of print. PMID: 35038229.

31. Malhotra S, Mani K, Lodha R, Bakhshi S, Mathur VP, Gupta P et al SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India. JAMA NetwOpen. 2022 Jan 4;5(1):e2142210. doi: 10.1001/jamanetworkopen.2021.42210. PMID: 34994793; PMCID: PMC8742193.

32. Markandey M, Bajaj A, Ilott NE, Kedia S, Travis S, Powrie F et al. Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease. Gut Microbes. 2021 Jan-Dec;13(1):1990827. doi: 10.1080/19490976.2021.1990827. PMID: 34747326; PMCID: PMC8583176.

33. Sharma S, Ahuja V. Liver Abscess: Complications and Treatment. Clin Liver Dis (Hoboken). 2021 Jul 16;18(3):122-126. doi: 10.1002/cld.1128. PMID: 34691398; PMCID: PMC8518335.

34. Vuyyuru SK, Kedia S, Kalaivani M, Sahu P, Kante B, Kumar P et al. Efficacy and safety of fecal transplantation versus targeted therapies in ulcerative colitis: network meta- analysis. Future Microbiol. 2021 Oct;16:1215-1227. doi: 10.2217/fmb-2020-0242. Epub 2021 Sep 30. PMID: 34590904.

35. Khan IA, Nayak B, Markandey M, Bajaj A, Verma M, Kumar S, Singh MK et al. Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn's disease and intestinal tuberculosis. PLoS One. 2021 Aug 18;16(8):e0256098. doi: 10.1371/journal.pone.0256098. PMID: 34407136; PMCID: PMC8372915.

36. Singh SP, Ahuja V, Ghoshal UC, Makharia G, Dutta U, Zargar SA et al. Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2021 Aug;40(4):420-444. doi: 10.1007/s12664-021-01186-4. Epub 2021 Jul 5. PMID: 34219211.

37. Chawla M, Mukherjee T, Deka A, Chatterjee B, Sarkar UA, Singh AK et al. An epithelial Nfkb2 pathway exacerbates intestinal inflammation by supplementing latent RelA dimers to the canonical NF-κB module. Proc Natl Acad Sci U S A. 2021 Jun 22;118(25):e2024828118. doi: 10.1073/pnas.2024828118. PMID: 34155144; PMCID: PMC8237674.

38. Vuyyuru SK, Kante B, Kumar P, Sahu P, Kedia S, Ranjan MK et al. Real world analysis on the efficacy and safety of anti- tumor necrosis factor therapy in patients with stricturing Crohn's disease. Sci Rep. 2021 Jun 3;11(1):11704. doi: 10.1038/s41598-021-90660-2. PMID: 34083575; PMCID: PMC8175366.

39. Sahu P, Kedia S, Ahuja V, Tandon RK. Diet and nutrition in the management of inflammatory bowel disease. Indian J Gastroenterol. 2021 Jun;40(3):253-264. doi: 10.1007/s12664-021-01163-x. Epub 2021 May 26. PMID: 34037954.

40. Kedia S, Sharma R, Vuyyuru SK, Madhu D, Sahu P, Kante B et al. Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis. Intest Res. 2022 Apr;20(2):184-191. doi: 10.5217/ir.2020.00104. Epub 2021 May 4. PMID: 33934587.

41. Wong SY, Dixon R, Martinez Pazos V, Gnjatic S, Colombel JF, Cadwell K; ICARUS-IBD Working Group. Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies. Gastroenterology. 2021 Aug;161(2):715-718.e4. doi: 10.1053/j.gastro.2021.04.025. Epub 2021 Apr 20. PMID: 33887219; PMCID: PMC8055494.

42. Dubinsky MC, Collins R, Abreu MT; International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). Challenges and Opportunities in IBD Clinical Trial Design. Gastroenterology. 2021 Aug;161(2):400-404. doi: 10.1053/j.gastro.2021.03.065. Epub 2021 Apr 20. PMID: 33864796.

43. Singh A, Mahajan R, Kedia S, Dutta AK, Anand A, Bernstein CN et al. Use of thiopurines in inflammatory bowel disease: an update. Intest Res. 2022 Jan;20(1):11-30. doi: 10.5217/ir.2020.00155. Epub 2021 Apr 15. PMID: 33845546; PMCID: PMC8831775.

44. Boparai G, Kedia S, Kandasamy D, Sharma R, Madhusudhan KS, Dash NR et al. Combination of sarcopenia and high visceral fat predict poor outcomes in patients with Crohn's disease. Eur J Clin Nutr. 2021 Oct;75(10):1491-1498. doi: 10.1038/s41430-021-00857-x. Epub 2021 Feb 2. PMID: 33531636.

45. Mahajan R, Singh A, Kedia S, Kaur K, Midha V, Sahu P et al. Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study. Intest Res. 2022 Jan;20(1):64-71. doi: 10.5217/ir.2020.00100. Epub 2021 Feb 3. PMID: 33525859; PMCID: PMC8831781.

46. Siegel CA, Melmed GY, McGovern DP, Rai V, Krammer F, Rubin DT, Abreu MT, Dubinsky MC; International Organization for the Study of Inflammatory Bowel Disease (IOIBD); International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. Gut. 2021 Apr;70(4):635-640. doi: 10.1136/gutjnl-2020-324000. Epub 2021 Jan 20. PMID: 33472895; PMCID: PMC7818789.

47. Jain S, Namdeo D, Sahu P, Kedia S, Sahni P, Das P et al. High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis. Intest Res. 2021 Oct;19(4):438-447. doi: 10.5217/ir.2020.00055. Epub 2020 Nov 6. PMID: 33147897; PMCID: PMC8566826.

48. Makharia GK, Singh P, Catassi C, Sanders DS, Leffler D, Ali RAR, Bai JC. The global burden of coeliac disease: opportunities and challenges. Nat Rev Gastroenterol Hepatol. 2022; 19: 313-327.

49. Makharia G, Gibson PR, Bai JC, Karakan T, Lee YY, Collins L et al. World Gastroenterology Organisation Global Guidelines: Diet and the Gut. J Clin Gastroenterol. 2022; 56: 1-15.

50. Kamat N, Vuyyuru SK, Kedia S, Sahu P, Kante B, Kumar P et al. Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis. Intest Res. 2022. doi: 10.5217/ir.2021.00064. Epub ahead of print.

51. Dhochak N, Singh A, Malik R, Jat KR, Sankar J, Makharia G, Kabra SK, Lodha R. Acute gastrointestinal injury in critically ill children: Impact on clinical outcome. J Paediatr Child Health. 2022; 58: 649-654.

52. Prasad K, Dwivedi SN, Kant S, Vibha D, Pandit AK, Karthikeyan G et al. Cohort Profile: The LoCARPoN-a population-based prospective cohort study in middle-aged and older adults in India. Int J Epidemiol. 2022; 51: 29-30.

53. Kumar A, Tripathi SN, Mittal S, Abraham J, Makharia GK, Parshad R. Symptomatic and Physiological Outcomes Following Laparoscopic Heller Myotomy for Achalasia Cardia: Is There a Correlation? Surg LaparoscEndoscPercutan Tech. 2022. doi: 10.1097/SLE.0000000000001034. Epub ahead of print. 

54. Kante B, Sahu P, Kedia S, Vuyyuru SK, Soni K, Singhal M et al. Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn's disease: a pilot study. Intest Res. 2022. doi: 10.5217/ir.2021.00056. Epub ahead of print. 

55. Kumar P, Vuyyuru SK, Kante B, Sahu P, Goyal S, Madhu D et al. Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti-TNF therapy in tuberculosis endemic region. Aliment PharmacolTher. 2022. doi: 10.1111/apt.16839. Epub ahead of print.

56. Dalal N, Jalandra R, Bayal N, Yadav AK, Harshulika, Sharma M et al. Gut microbiota-derived metabolites in CRC progression and causation. J Cancer Res Clin Oncol. 2021;147:3141-3155.

57. Mohta S, Rajput MS, Ahuja V, Makharia GK. Emergence of Celiac disease and Gluten-related disorders in Asia. J NeurogastroenterolMotil. 2021; 27: 337-346. 

58. Aggarwal N, Dwarakanathan V, Singh A, Agarwal A, Khuttan A, Ahmed A et al. Spectrum of height in patients with celiac disease. Indian J Gastroenterol. 2021; 40: 604-612.

59. Bhattacharjee HK, Chaliyadan S, Verma E, Ramachandran R, Makharia G, Parshad R. Coronavirus disease 2019 and laparoscopic surgery in resource-limited settings. Asian J Endosc Surg. 2021; 14: 305-308.

60. Nigam GB, Patel RN, Lakhtakia S, Desai D, Makharia G, Ahuja V, Limdi JK. A Survey of Endoscopists' Views on Dysplasia Surveillance and Chromoendoscopy in IBD from India. Inflamm Bowel Dis. 2021. doi: 10.1093/ibd/izab308. Epub ahead of print. 

61. Shalimar, Vaishnav M, Elhence A, Kumar R, Mohta S, Palle C et al. Outcome of Conservative Therapy in Coronavirus disease-2019 Patients Presenting With Gastrointestinal Bleeding. J Clin Exp Hepatol. 2021; 11: 327-333.

62. Azhar M, Phutela R, Kumar M, Ansari AH, Rauthan R, Gulati S et al. Rapid and accurate nucleobase detection using FnCas9 and its application in COVID-19 diagnosis. BiosensBioelectron. 2021 Jul 1;183:113207.

63. Leddin D, Omary MB, Veitch A, Metz G, Amrani N, Aabakken L et al. Uniting the Global Gastroenterology Community to Meet the Challenge of Climate Change and Non-Recyclable Waste. Gastroenterology. 2021; 161: 1354-1360.

64. Leddin D, Omary MB, Veitch A, Metz G, Amrani N, Aabakken L et al. Uniting the global gastroenterology community to meet the challenge of climate change and non-recyclable waste. Gut. 2021; 70: 2025-2029.  

65. Singh AD, Ellias S, Singh P, Ahuja V, Makharia GK. The Prevalence of the Celiac Disease in Patients with Dyspepsia: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2021. doi: 10.1007/s10620-021-07142-8. Epub ahead of print.

66. Ahmed A, Singh A, Kajal S, Chauhan A, Rajput MS, Banyal V et al. Dental enamel defects and oral cavity manifestations in Asian patients with celiac disease. Indian J Gastroenterol. 2021; 40: 402-409.

67. Sharma S, Gupta A, Kedia S, Agarwal S, Singh N, Goyal S et al. Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn's disease. Intest Res. 2021; 19: 291-300.

68. Dutta R, Iqbal A, Das P, Palanichamy JK, Singh A, Mehtab W et al. Liver involvement in patients with coeliac disease: proof of causality using IgA/anti-TG2 colocalisation techniques. J Clin Pathol. 2021; 74: 766-773. 

69. Mehtab W, Sachdev V, Singh A, Agarwal S, Singh N, Malik R et al. Gluten content in labeled and unlabeled gluten-free food products used by patients with celiac disease. Eur J Clin Nutr. 2021; 75: 1245-1253.

70. Rampal R, Kedia S, Wari MN, Madhu D, Singh AK, Tiwari V e tla. Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn's disease. Intest Res. 2021; 19: 232-238. 

71. Antonelli G, Karstensen JG, Bhat P, Ijoma U, Osuagwu C, Desalegn H et al. Endoscopy and COVID-19 Cascade Working Group, European Society of Gastrointestinal Endoscopy, World Endoscopy Organization and World Gastroenterology Organization. Erratum: Resuming endoscopy during COVID-19 pandemic: ESGE, WEO and WGO Joint Cascade Guideline for Resource Limited Settings. Endosc Int Open. 2021; 9: C4.

72. Vuyyuru SK, Kante B, Kumar P, Sahu P, Kedia S, Ranjan MK et al. Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn's disease. Sci Rep. 2021; 11: 11704.

73. Mehtab W, Chauhan A, Agarwal A, Singh A, Rajput MS, Mohta S et al. Impact of Corona Virus Disease 2019 pandemic on adherence to gluten-free diet in Indian patients with celiac disease. Indian J Gastroenterol. 2021; 40: 613-620.

74. Ramakrishna BS, Venugopal G, Singh A, Pugazhendhi S, Dutta S, Ahuja V, Makharia GK. Human Leukocyte Antigen DQ (HLA-DQ) genotypes and haplotypes and their association with phenotype in patients with celiac disease in India. JGH Open. 2021; 5:1190-1196. 

75. Das P, Vaiphei K, Amarapurkar AD, Sakhuja P, Nada R, Paulose RR et la. Best practices of handling, processing, and interpretation of small intestinal biopsies for the diagnosis and management of celiac disease: A joint consensus of Indian association of pathologists and microbiologists and Indian society of gastroenterology. Indian J PatholMicrobiol. 2021; 64: S8-S31.

76. Chauhan A, Das P, Singh A, Dutta R, Rajeshwari M, Rajput MS et al. Pan-Gastrointestinal Tract Mucosal Pathologies in Patients with Celiac Disease with the Demonstration of IgA Anti-Transglutaminase Mucosal Deposits: A Case-Control Study. Dig Dis Sci. 2021. doi: 10.1007/s10620-021-07246-1. Epub ahead of print. 

77. Anand A, Biswas S, Vaishnav M, Gamanagatti SR, Elhence A, Jindal V et al. Clinical Utility of Transient Elastography in the Management of Patients with Budd Chiari Syndrome undergoing Endovascular Intervention. J VascIntervRadiol. 2021 Nov 16:S1051-0443(21)01475-5. doi:10.1016/j.jvir.2021.11.003. Epub ahead of print. PMID: 34798289.

78. Nayak B, Lal G, Kumar S, Das CJ, Saraya A, Shalimar. Host Response to SARS- CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.Front Cell Infect Microbiol. 2021 Oct 25;11:753249. doi:10.3389/fcimb.2021.753249. PMID: 34760721; PMCID: PMC8573081.

79. Elhence A, Vaishnav M, Biswas S, Anand A, Gunjan D, Kedia S et al. Predictors of in-hospital outcomes in patients with Cirrhosis and Coronavirus disease-2019. J Clin Exp Hepatol. 2021 Oct 29. doi: 10.1016/j.jceh.2021.10.014. Epub ahead of print. PMID: 34728983; PMCID: PMC8553413.

80. Anand A, Shalimar. Hepatitis C virus in India: Challenges and Successes. Clin Liver Dis (Hoboken). 2021 Jul 22;18(3):150-154. doi: 10.1002/cld.1137. PMID:34691402; PMCID: PMC8518332.

81. Alabsawy E, Shalimar, Jalan R. Potential novel approaches to prevent the risk of infection in patients with variceal bleeding. J Hepatol. 2021 Oct 1:S0168-8278(21)02089-4. doi: 10.1016/j.jhep.2021.09.027. Epub ahead of print. PMID: 34606911.

82. Saha R, Pradhan SS, Shalimar, Das P, Mishra P, Singh R, Sivaramakrishnan V, Acharya P. Inflammatory signature in acute-on-chronic liver failure includes increased expression of granulocyte genes ELANE, MPO and CD177. Sci Rep. 2021 Sep 22;11(1):18849. doi: 10.1038/s41598-021-98086-6. PMID: 34552111; PMCID:PMC8458283.

83. Sharma D, Shalimar. COVID-19: Finally on wane, with reduced lethality. Comb Chem High Throughput Screen. 2021 Aug 11. doi:10.2174/1386207324666210811130046. Epub ahead of print. PMID: 34382508.

84. Anand A, Shalimar, Jana M, Kandasamy D, Kumar B, Singh G, Jain V. Usefulness of Controlled Attenuation Parameter for Identification and Grading of Nonalcoholic Fatty Liver Disease in Adolescents with Obesity. Indian J Pediatr. 2021 Jul 29. doi: 10.1007/s12098-021-03842-1. Epub ahead of print. PMID:34324132.

85. Elhence A, Shalimar. Hepatic Tuberculosis: A Wolf in Sheep's Clothing. J Clin Exp Hepatol. 2021 Jul-Aug;11(4):521. doi: 10.1016/j.jceh.2021.04.001. Epub 2021 Apr 8. PMID: 34276162; PMCID: PMC8267350.

86. Malla S, Sharma R, Goyal A, Shalimar. Pyogenic liver abscess complicated by a hepatoduodenal fistula. BMJ Case Rep. 2021 Jul 7;14(7):e242693. doi:10.1136/bcr-2021-242693. PMID: 34233866; PMCID: PMC8246290.

87. Arora C, Malhotra A, Ranjan P, Vikram NK, Dwivedi SN, Singh N, Shalimar. Perceived barriers and facilitators for adherence to lifestyle prescription: Perspective of obese patients with non alcoholic fatty liver disease from north India. Diabetes MetabSyndr. 2021 Jul-Aug;15(4):102138. doi:10.1016/j.dsx.2021.05.011. Epub 2021 May 17. PMID: 34186359.

88. Anand A, Gamanagatti SR, Vaishnav M, Shalimar. Hepatic Infarction after Transjugular Intrahepatic Shunt Creation. J VascIntervRadiol. 2021 Oct;32(10):1513. doi: 10.1016/j.jvir.2021.06.004. Epub 2021 Jun 22. PMID:34166804.

89. Ghosh A, Yadav R, Shalimar, Gamanagatti S. Respiratory triggered diffusion- weighted imaging with a single diffusion sensitising gradient to reduce image acquisition time - A feasibility study in the workup of hepatocellular carcinoma. Eur J Radiol. 2021 Aug;141:109807. doi: 10.1016/j.ejrad.2021.109807. Epub 2021 Jun 3. PMID: 34146912.

90. Vallonthaiel AG, Baloda V, Singh L, Yadav R, Kilambi R, Battu S et al. Histological analyses of trucut liver biopsies from patients with noncirrhotic portal fibrosis and extra-hepatic portal vein obstruction. Indian J PatholMicrobiol. 2021 Jun;64(Supplement):S127-S135. doi: 10.4103/IJPM.IJPM_387_20. PMID: 34135154.

91. Arora U, Garg P, Agarwal S, Nischal N, Shalimar, Wig N. Complexities in the treatment of coinfection with HIV, hepatitis B, hepatitis C, and tuberculosis. Lancet Infect Dis. 2021 May 20:S1473-3099(20)30765-9. doi:10.1016/S1473-3099(20)30765-9. Epub ahead of print. Erratum in: Lancet Infect Dis. 2021 Jul;21(7):e182. PMID: 34023004.

92. Elhence A, Vaishnav M, Biswas S, Chauhan A, Anand A, Shalimar. CoronavirusDisease-2019 (COVID-19) and the Liver. J Clin Transl Hepatol. 2021 Apr 28;9(2):247-255. doi: 10.14218/JCTH.2021.00006. Epub 2021 Mar 22. PMID:34007807; PMCID: PMC8111098.

93. Srivastava A, Parambath HK, Ramdulari AV, Saxena H, Kumar R, Pandey S,Shalimar, Gupta S, Jee B. Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form ofstereotactic body radiation therapy? Int J Radiat Biol. 2022 Mar 21:1-54. doi: 10.1080/09553002.2022.2055800. Epub ahead of print. PMID: 35311612.

94. Alabsawy E, Shalimar, Jalan R. Editorial: infections and hepatic encephalopathy-does the chicken or the egg come first? A novel perspective at the horizon. Authors' reply. Aliment PharmacolTher. 2022 Mar;55(6):746-747. doi: 10.1111/apt.16829. PMID: 35245963.

95. Elhence A, Anand A, Shalimar. Reply to "Re: Clinical utility of transient elastography in the management of patients with Budd-Chiari syndrome undergoing endovascular intervention.". J VascIntervRadiol. 2022 Feb 24:S1051-0443(22)00089-6. doi: 10.1016/j.jvir.2022.02.014. Epub ahead of print. PMID: 35218922.

96. Asadullah M, Shivashankar R, Shalimar, Kandasamy D, Kondal D, Rautela G et al. Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population. PLoS One. 2022 Feb 10;17(2):e0263768. doi: 10.1371/journal.pone.0263768. PMID: 35143562; PMCID: PMC8830644.

97. Alabsawy E, Shalimar, Sheikh MF, Ballester MP, Acharya SK, Agarwal B, Jalan R. Overt hepatic encephalopathy is an independent risk factor for de novo infection in cirrhotic patients with acute decompensation. Aliment PharmacolTher. 2022 Mar;55(6):722-732. doi: 10.1111/apt.16790. Epub 2022 Feb 1. PMID: 35106777.

98. Duseja A, Singh SP, Mehta M, Shalimar, Venkataraman J, Mehta V et al. Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease. MetabSyndrRelatDisord. 2022 Jan 25. doi: 10.1089/met.2021.0104. Epub ahead of print. PMID: 35085026.

99. Sehgal T, Aggarwal M, Baitha U, Gupta G, Prakash B, Gupta A et al. Thromboelastography determined dynamics of blood coagulation and its correlation with complications and outcomes in patients with coronavirus disease 2019. Res PractThrombHaemost. 2022 Jan 15;6(1):e12645. doi: 10.1002/rth2.12645. PMID: 35071969; PMCID: PMC8760607.

100. Farooqui N, Elhence A, Shalimar. A Current Understanding of Bile Acids in Chronic Liver Disease. J Clin Exp Hepatol. 2022 Jan-Feb;12(1):155-173. doi: 10.1016/j.jceh.2021.08.017. Epub 2021 Aug 23. PMID: 35068796; PMCID: PMC8766695.

101. Ray AK, Luis PB, Mishra SK, Barry DP, Asim M, Pandey A et la. Curcumin Oxidation Is Required for Inhibition of Helicobacter pylori Growth, Translocation and Phosphorylation of Cag A. Front Cell Infect Microbiol. 2021 Dec 24;11:765842. doi: 10.3389/fcimb.2021.765842. PMID: 35004346; PMCID: PMC8740292.

102. Elhence A, Shalimar. Liver dysfunction in Barcelona Clinic Liver Cancer-2022 update: Clear as day or still in fog? J Hepatol. 2021 Dec 23: S0168-8278(21)02291-1. doi: 10.1016/j.jhep.2021.12.016. Epub ahead of print. PMID: 34954248.

103. Vaishnav M, Elhence A, Biswas S, Pathak P, Anand A, Sheikh S et al. The Outcome after Hospital Discharge in Cirrhosis is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis. J Clin Exp Hepatol. 2021 Nov 24. doi: 10.1016/j.jceh.2021.11.009. Epub ahead of print. PMID: 34840484; PMCID: PMC8610830.

104. Anand A, Biswas S, Vaishnav M, Gamanagatti SR, Elhence A, Jindal V, Banyal V, Singh V, Kumar R, Shalimar. Clinical Utility of Transient Elastography in the Management of Patients with Budd-Chiari Syndrome Undergoing Endovascular Intervention. J VascIntervRadiol. 2022 Mar;33(3):268-277.e3. doi:10.1016/j.jvir.2021.11.003. Epub 2021 Nov 16. PMID: 34798289.

105. Goel N, Kaur S, Gunjan D, Mahapatra SJ. Investigating the significance of color space for abnormality detection in wireless capsule endoscopy images. Biomedical Signal Processing and Control. 2022, volume 75, 103624. doi.org/10.1016/j.bspc.2022.103624.

106. S Kaur, Goel N, Gunjan D, Mahapatra S. Dilated CNN for abnormality detection in wireless capsule endoscopy images. Soft Comput. 2022, 26, 3, 1231–1247. https://doi.org/10.1007/s00500-021-06546-y

107. Sarkar S, Khanna P, Gunjan D. Anesthesia for Per-oral endoscopic myotomy (POEM) – not so poetic! J Anaesthesiol Clin Pharmacol2022;38:28-34.

108. Jadaun SS, Sharma S, Madhusudhan KS, Sharma R, Nayak B, Kedia S et al. Spectrum of neuroimaging abnormalities in brain in patients of acute on chronic liver failure. J Clin Exp Hepatol. 2021. https:// doi.org/10.1016/j.jceh.2021.08.007

109. Madhusudhan KS, Gopi S, Singh AN, Agarwal L, Gunjan D, Srivastava DN et al. Immediate and long term outcomes of percutaneous radiological interventions for hemorrhagic complications in acute and chronic pancreatitis: a seven year experience from a tertiary care centre. J VascIntervRadiol. 2021 Aug 17:S1051-0443(21)01281-1. doi: 10.1016/j.jvir.2021.08.004.

110. Anand A, Singh AA, Elhence A, Vaishnav M, Biswas S, Gunjan D et al. Prevalence and predictors of non-alcoholic fatty liver disease in family members of patients with non-alcoholic fatty liver disease, J Clin Exp Hepatol 2021. https://doi.org/10.1016/j.jceh.2021.07.013.

111. Angadi S, Mahapatra SJ, Sethia R, Elhence A, Krishna A, Gunjan D et al. Endoscopic transmural drainage tailored to quantity of necrotic debris versus laparoscopic transmural internal drainage for walled-off necrosis in acute pancreatitis: A randomized controlled trial, Pancreatology. 2021 Oct;21(7):1291-1298.

112. Mahapatra SJ, Midha S, Teja GV, et al. Clinical Course of Chronic Pancreatitis During Pregnancy and its Effect on Maternal and Fetal Outcomes. Am J Gastroenterol 2021;116:600–608.

113. Samanta J, Mahapatra SJ, Kumar N, et al. Virus related acute pancreatitis and virus superinfection in the “Dual disease” model of acute pancreatitis and SARS-Co-V2 infection: A multicentre prospective study. Pancreatol Off J IntAssocPancreatol IAP Al 2022;22:339–347.

114. Elhence A, Mahapatra SJ, Madhusudhan KS, et al. Pancreatic hemorrhage contributes to late mortality in patients with acute necrotizing pancreatitis. Pancreatol Off J IntAssocPancreatol IAP Al 2022;22:219–225.

115. Sahoo SM, Mahapatra SJ. Intrahepatic cholestasis of pregnancy: are we expecting too much from ursodeoxycholic acid? Lancet Gastroenterol Hepatol2021;6:886.

116. Prasanth J, Prasad M, Mahapatra SJ, et al. Early Versus Delayed Cholecystectomy for Acute Biliary Pancreatitis: A Systematic Review and Meta-Analysis. World J Surg 2022.

117. Elhence A, Mahapatra SJ, Garg PK. A Review of Acute Pancreatitis. JAMA 2021;325:2403.

118. Shah R, Basha J, Rana S, et al. Endoscopic Management of Pancreatic Fluid Collections: Guidelines of Society of Gastrointestinal Endoscopy of India and Indian EUS Club. Journal of Digestive Endoscopy 2021;12:003–010.

Chapter in Books (2019-20)

 

Authors	Chapter Title	Name of editors	Book	Publisher	Year	pages
Makharia GK	Abdominal tuberculosis	Sharma SK, Mohan Alladi	Textbook of Tuberculosis and Non-tuberculous Mycobacterial diseases	Jaypee Brothers Medical Publishers	2020	208-221
Singh Prashant, Makharia GK	Food allergy and food hypersensitivity	Rao SSC, Young Yeh Lee, Ghoshal UC	Clinical and Basic Neurogastroenterology and Motility	Elsevier, Academic Press	2020	387-395
Anand Abhinav, Agarwal Ashish, Makharia GK	Non-celiac gluten sensitivity	Ajay Kumar	Gastroenterology Annual		2019

 

Chapters in Books

SNo	Author of Chapter	Chapter Title	Name of editor	Name of the book	Edn.	City of publication	Publisher	Year of pub.	First last page
1	Alka Singh, Pooja, Govind K Makharia	Citrulline as a marker of villous abnormality and implications for diet and nutrition	Victor Preedy	Biomarkers in Disease: Methods, Discoveries and Applica		London	Springer Nature	2022	Under Printing

 Chapter in Books

1. Umesh Kapil, Neha Sareen. National Nutritional Programmes in India. A book on "Child Nutrition & Diet -- Simplified". Edited by Meenakshi Mehta. Chapter 20.

2. Amit Kavimandan, Govind K Makharia. Probiotics in inflammatory bowel disease. In: Rama Chaudhry (Ed). Probiotics..Kontentworx, New Delhi. 2013. Pp 64-84.

3. Prashnat Singh, V PratapMouli. Microscopic colitis. In: BS Ramakrishna BS (Ed). Inflamatory bowel disease. Elsevier India, New Delhi, 2013.pp

4. Amit Kavimandan, Govind K Makharia. Probiotics in inflammatory bowel disease. In: Rama Chaudhry (Ed). Probiotics..Kontentworx, New Delhi. 2013. Pp 64-84.

5. Prashnat Singh, V PratapMouli. Microscopic colitis. In: BS Ramakrishna BS ( Ed). Inflamatory bowel disease. Elsevier India, New Delhi, 2013.pp
    

Significant Events

Dr. Umesh Kapil

1. Dr. Umesh Kapil was a member of the Meeting of Human Resource Development and Health and Family Welfare in context of National Food Security Ordinance (NFSO) and implementation of Mid-Day Meals Scheme by Planning Commission, Yojana Bhavan, New Delhi on 2nd August 2013
2. Dr. Umesh Kapil was a member of the Advisory Panel of National Academy of Medical Sciences (NAMS) in the discipline of Nutrition for advising the Credential Committee in the Selection of candidates for Fellowship of the Academy for the year 2014
3. Dr. Govind Makharia Organized a World Gastroenterology Organization and Asia Pacific Association of Gastroenterology Working Party meeting on Celiac Disease in Asia-Pacific region
4. Dr.Govind Makharia Organized Young Clinician Program in Mumbai on behalf of Indian Society of Gastroenterology;
5. Dr.Govind Makharia was coordinator Indian Consensus on Standardization of pathology and endoscopic reporting of inflammatory bowel disease, in Chennai.
    

Visiting Scientist

1. Dr. Hari Conjeevaram, Medical Director, University of Michigan, USA visited the department on 4th October, 2013.

2. Dr. Patrick Kamath, Prof. of Gastroenterology, Mayo Clinic, USA visited the department on 23rd January, 2014.

3. Dr. Pratima Sharma, University of Michigan, USA visited the department on 24th March, 2013.